Document:

EXHIBIT 4.2

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER
LOAN SECURED BY SUCH SECURITIES.

                          COMMON STOCK PURCHASE WARRANT

                  To Purchase 200,000 Shares of Common Stock of

                         VELOCITY ASSET MANAGEMENT INC.

         THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for
value received, DKR Soundshore Oasis Holding Fund Ltd. (the "Holder"), is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the earlier of the 6
month anniversary of the completion of the Secondary Offering and the 9 month
anniversary of the date of the Purchase Agreement (the "Initial Exercise Date")
and on or prior to the close of business on the 5 year anniversary of the
Initial Exercise Date (the "Termination Date") but not thereafter, to subscribe
for and purchase from Velocity Asset Management Inc., a Delaware corporation
(the "Company"), up to 200,000 shares (the "Warrant Shares") of Common Stock,
par value $.001 per share, of the Company (the "Common Stock"). The purchase
price of one share of Common Stock under this Warrant shall be equal to the
Exercise Price, as defined in Section 2(b).

         Section 1.  Definitions. Capitalized terms used and not otherwise
defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the "Purchase Agreement"), dated October 27, 2005, among the
Company and the purchasers signatory thereto.

         Section 2.  Exercise.
         ---------   --------

                  a)       Exercise of Warrant. Exercise of the purchase rights
         represented by this Warrant may be made, in whole or in part, at any
         time or times on or after the Initial Exercise Date and on or before
         the Termination Date by delivery to the Company of a duly executed
         facsimile copy of the Notice of Exercise Form annexed hereto (or such
         other office or agency of the Company as it may designate by notice in
         writing to the registered Holder at the address of such Holder

                                       1
<PAGE>

         appearing on the books of the Company); provided, however, such
         exercise must be for a minimum of 5,000 shares; provided, further,
         however, within 5 Trading Days of the date said Notice of Exercise is
         delivered to the Company, if this Warrant is exercised in full, the
         Holder shall have surrendered this Warrant to the Company and the
         Company shall have received payment of the aggregate Exercise Price of
         the shares thereby purchased by wire transfer or cashier's check drawn
         on a United States bank. Notwithstanding anything herein to the
         contrary, the Holder shall not be required to physically surrender this
         Warrant to the Company until the Holder has purchased all of the
         Warrant Shares available hereunder and the Warrant has been exercised
         in full. Partial exercises of this Warrant resulting in purchases of a
         portion of the total number of Warrant Shares available hereunder shall
         have the effect of lowering the outstanding number of Warrant Shares
         purchasable hereunder in an amount equal to the applicable number of
         Warrant Shares purchased. The Holder and the Company shall maintain
         records showing the number of Warrant Shares purchased and the date of
         such purchases. The Company shall deliver any objection to any Notice
         of Exercise Form within 2 Business Days of receipt of such notice. In
         the event of any dispute or discrepancy, the records of the Holder
         shall be controlling and determinative in the absence of manifest
         error. The Holder and any assignee, by acceptance of this Warrant,
         acknowledge and agree that, by reason of the provisions of this
         paragraph, following the purchase of a portion of the Warrant Shares
         hereunder, the number of Warrant Shares available for purchase
         hereunder at any given time may be less than the amount stated on the
         face hereof.

                  b)       Exercise Price. The exercise price of the Common
         Stock under this Warrant shall be $3.10 subject to adjustment hereunder
         (the "Exercise Price").

                  c)       Cashless Exercise. If at any time after one year from
         the date of issuance of this Warrant there is no effective Registration
         Statement registering, or no current prospectus available for, the
         resale of the Warrant Shares by the Holder, then this Warrant may also
         be exercised at such time by means of a "cashless exercise" in which
         the Holder shall be entitled to receive a certificate for the number of
         Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)]
         by (A), where:

                  (A) = the VWAP on the Trading Day immediately preceding the
                        date of such election;

                  (B) = the Exercise Price of this Warrant, as adjusted; and

                  (X) = the number of Warrant Shares issuable upon exercise of
                        this Warrant in accordance with the terms of this
                        Warrant by means of a cash exercise rather than a
                        cashless exercise.

                  Notwithstanding anything herein to the contrary, on the
         Termination Date, this Warrant shall be automatically exercised via
         cashless exercise pursuant to this Section 2(c).

                                       2
<PAGE>

                  d)       Holder's Restrictions. The Company shall not effect
         any exercise of this Warrant, and a Holder shall not have the right to
         exercise any portion of this Warrant, pursuant to Section 2(c) or
         otherwise, to the extent that after giving effect to such issuance
         after exercise, such Holder (together with such Holder's affiliates,
         and any other person or entity acting as a group together with such
         Holder or any of such Holder's affiliates), as set forth on the
         applicable Notice of Exercise, would beneficially own in excess of
         4.99% of the number of shares of the Common Stock outstanding
         immediately after giving effect to such issuance. For purposes of the
         foregoing sentence, the number of shares of Common Stock beneficially
         owned by such Holder and its affiliates shall include the number of
         shares of Common Stock issuable upon exercise of this Warrant with
         respect to which the determination of such sentence is being made, but
         shall exclude the number of shares of Common Stock which would be
         issuable upon (A) exercise of the remaining, nonexercised portion of
         this Warrant beneficially owned by such Holder or any of its affiliates
         and (B) exercise or conversion of the unexercised or nonconverted
         portion of any other securities of the Company (including, without
         limitation, any other Preferred Stock or Warrants) subject to a
         limitation on conversion or exercise analogous to the limitation
         contained herein beneficially owned by such Holder or any of its
         affiliates. Except as set forth in the preceding sentence, for purposes
         of this Section 2(d)(i), beneficial ownership shall be calculated in
         accordance with Section 13(d) of the Exchange Act and the rules and
         regulations promulgated thereunder, it being acknowledged by a Holder
         that the Company is not representing to such Holder that such
         calculation is in compliance with Section 13(d) of the Exchange Act and
         such Holder is solely responsible for any schedules required to be
         filed in accordance therewith. To the extent that the limitation
         contained in this Section 2(d) applies, the determination of whether
         this Warrant is exercisable (in relation to other securities owned by
         such Holder) and of which a portion of this Warrant is exercisable
         shall be in the sole discretion of a Holder, and the submission of a
         Notice of Exercise shall be deemed to be each Holder's determination of
         whether this Warrant is exercisable (in relation to other securities
         owned by such Holder) and of which portion of this Warrant is
         exercisable, in each case subject to such aggregate percentage
         limitation, and the Company shall have no obligation to verify or
         confirm the accuracy of such determination. In addition, a
         determination as to any group status as contemplated above shall be
         determined in accordance with Section 13(d) of the Exchange Act and the
         rules and regulations promulgated thereunder. For purposes of this
         Section 2(d), in determining the number of outstanding shares of Common
         Stock, a Holder may rely on the number of outstanding shares of Common
         Stock as reflected in (x) the Company's most recent Form 10-QSB or Form
         10-KSB, as the case may be, (y) a more recent public announcement by
         the Company or (z) any other notice by the Company or the Company's
         Transfer Agent setting forth the number of shares of Common Stock
         outstanding. Upon the written or oral request of a Holder, the Company
         shall within two Trading Days confirm orally and in writing to such
         Holder the number of shares of Common Stock then outstanding. In any
         case, the number of outstanding shares of Common Stock shall be
         determined after giving effect to the conversion or exercise of
         securities of the Company, including this Warrant, by such Holder or
         its affiliates since the date as of which such number of outstanding
         shares of Common Stock was reported. The provisions of this Section
         2(d) may be waived by such Holder, at the election of such Holder, upon
         not less than 61 days' prior notice to the Company, and the provisions

                                       3
<PAGE>

         of this Section 2(d) shall continue to apply until such 61st day (or
         such later date, as determined by such Holder, as may be specified in
         such notice of waiver). The provisions of this paragraph shall be
         implemented in a manner otherwise than in strict conformity with the
         terms of this Section 2(d) to correct this paragraph (or any portion
         hereof) which may be defective or inconsistent with the intended 4.99%
         beneficial ownership limitation herein contained or to make changes or
         supplements necessary or desirable to properly give effect to such
         4.99% limitation. The limitations contained in this paragraph shall
         apply to a successor holder of this Warrant. The holders of Common
         Stock of the Company shall be third party beneficiaries of this Section
         2(d) and the Company may not waive this Section 2(d) without the
         consent of holders of a majority of its Common Stock.

         e)       Mechanics of Exercise.
                  ---------------------

                           i.       Authorization of Warrant Shares. The Company
                  covenants that all Warrant Shares which may be issued upon the
                  exercise of the purchase rights represented by this Warrant
                  will, upon exercise of the purchase rights represented by this
                  Warrant, be duly authorized, validly issued, fully paid and
                  nonassessable and free from all taxes, liens and charges in
                  respect of the issue thereof (other than taxes in respect of
                  any transfer occurring contemporaneously with such issue).

                           ii.      Delivery of Certificates Upon Exercise.
                  Certificates for shares purchased hereunder shall be
                  transmitted by the transfer agent of the Company to the Holder
                  by crediting the account of the Holder's prime broker with the
                  Depository Trust Company through its Deposit Withdrawal Agent
                  Commission ("DWAC") system if the Company is a participant in
                  such system, and otherwise by physical delivery to the address
                  specified by the Holder in the Notice of Exercise within 5
                  Trading Days from the delivery to the Company of the Notice of
                  Exercise Form, surrender of this Warrant (if required) and
                  payment of the aggregate Exercise Price as set forth above
                  ("Warrant Share Delivery Date"). This Warrant shall be deemed
                  to have been exercised on the date the Exercise Price is
                  received by the Company. The Warrant Shares shall be deemed to
                  have been issued, and Holder or any other person so designated
                  to be named therein shall be deemed to have become a holder of
                  record of such shares for all purposes, as of the date the
                  Warrant has been exercised by payment to the Company of the
                  Exercise Price and all taxes required to be paid by the
                  Holder, if any, pursuant to Section 2(e)(vii) prior to the
                  issuance of such shares, have been paid.

                           iii.    Delivery of New Warrants Upon Exercise. If
                  this Warrant shall have been exercised in part, the Company
                  shall, at the request of a Holder and upon surrender of this
                  Warrant certificate, at the time of delivery of the
                  certificate or certificates representing Warrant Shares,
                  deliver to Holder a new Warrant evidencing the rights of
                  Holder to purchase the unpurchased Warrant Shares called for
                  by this Warrant, which new Warrant shall in all other respects
                  be identical with this Warrant.

                                       4
<PAGE>

                           iv.      Rescission Rights. If the Company fails to
                  cause its transfer agent to transmit to the Holder a
                  certificate or certificates representing the Warrant Shares
                  pursuant to this Section 2(e)(iv) by the Warrant Share
                  Delivery Date, then the Holder will have the right to rescind
                  such exercise.

                           v.       Compensation for Buy-In on Failure to Timely
                  Deliver Certificates Upon Exercise. In addition to any other
                  rights available to the Holder, if the Company fails to cause
                  its transfer agent to transmit to the Holder a certificate or
                  certificates representing the Warrant Shares pursuant to an
                  exercise on or before the Warrant Share Delivery Date, and if
                  after such date the Holder is required by its broker to
                  purchase (in an open market transaction or otherwise) shares
                  of Common Stock to deliver in satisfaction of a sale by the
                  Holder of the Warrant Shares which the Holder anticipated
                  receiving upon such exercise (a "Buy-In"), then the Company
                  shall (1) pay in cash to the Holder the amount by which (x)
                  the Holder's total purchase price (including brokerage
                  commissions, if any) for the shares of Common Stock so
                  purchased exceeds (y) the amount obtained by multiplying (A)
                  the number of Warrant Shares that the Company was required to
                  deliver to the Holder in connection with the exercise at issue
                  times (B) the price at which the sell order giving rise to
                  such purchase obligation was executed, and (2) at the option
                  of the Holder, either reinstate the portion of the Warrant and
                  equivalent number of Warrant Shares for which such exercise
                  was not honored or deliver to the Holder the number of shares
                  of Common Stock that would have been issued had the Company
                  timely complied with its exercise and delivery obligations
                  hereunder. For example, if the Holder purchases Common Stock
                  having a total purchase price of $11,000 to cover a Buy-In
                  with respect to an attempted exercise of shares of Common
                  Stock with an aggregate sale price giving rise to such
                  purchase obligation of $10,000, under clause (1) of the
                  immediately preceding sentence the Company shall be required
                  to pay the Holder $1,000. The Holder shall provide the Company
                  written notice indicating the amounts payable to the Holder in
                  respect of the Buy-In, together with applicable confirmations
                  and other evidence reasonably requested by the Company.
                  Nothing herein shall limit a Holder's right to pursue any
                  other remedies available to it hereunder, at law or in equity
                  including, without limitation, a decree of specific
                  performance and/or injunctive relief with respect to the
                  Company's failure to timely deliver certificates representing
                  shares of Common Stock upon exercise of the Warrant as
                  required pursuant to the terms hereof.

                           vi.      No Fractional Shares or Scrip. No fractional
                  shares or scrip representing fractional shares shall be issued
                  upon the exercise of this Warrant. As to any fraction of a
                  share which Holder would otherwise be entitled to purchase

                                       5
<PAGE>

                  upon such exercise, the Company shall pay a cash adjustment in
                  respect of such final fraction in an amount equal to such
                  fraction multiplied by the Exercise Price.

                           vii.     Charges, Taxes and Expenses. Issuance of
                  certificates for Warrant Shares shall be made without charge
                  to the Holder for any issue or transfer tax or other
                  incidental expense in respect of the issuance of such
                  certificate, all of which taxes and expenses shall be paid by
                  the Company, and such certificates shall be issued in the name
                  of the Holder or in such name or names as may be directed by
                  the Holder; provided, however, that in the event certificates
                  for Warrant Shares are to be issued in a name other than the
                  name of the Holder, this Warrant when surrendered for exercise
                  shall be accompanied by the Assignment Form attached hereto
                  duly executed by the Holder; and the Company may require, as a
                  condition thereto, the payment of a sum sufficient to
                  reimburse it for any transfer tax incidental thereto.

                           viii.    Closing of Books. The Company will not close
                  its stockholder books or records in any manner which prevents
                  the timely exercise of this Warrant, pursuant to the terms
                  hereof.

         Section 3.  Certain Adjustments.
         ---------   -------------------

                  a)       Stock Dividends and Splits. If the Company, at any
         time while this Warrant is outstanding: (A) pays a stock dividend or
         otherwise make a distribution or distributions on shares of its Common
         Stock or any other equity or equity equivalent securities payable in
         shares of Common Stock (which, for avoidance of doubt, shall not
         include any shares of Common Stock issued by the Company pursuant to
         this Warrant), (B) subdivides outstanding shares of Common Stock into a
         larger number of shares, (C) combines (including by way of reverse
         stock split) outstanding shares of Common Stock into a smaller number
         of shares, or (D) issues by reclassification of shares of the Common
         Stock any shares of capital stock of the Company, then in each case the
         Exercise Price shall be multiplied by a fraction of which the numerator
         shall be the number of shares of Common Stock (excluding treasury
         shares, if any) outstanding immediately before such event and of which
         the denominator shall be the number of shares of Common Stock
         outstanding immediately after such event and the number of shares
         issuable upon exercise of this Warrant shall be proportionately
         adjusted. Any adjustment made pursuant to this Section 3(a) shall
         become effective immediately after the record date for the
         determination of stockholders entitled to receive such dividend or
         distribution and shall become effective immediately after the effective
         date in the case of a subdivision, combination or re-classification.

                  b)       Subsequent Equity Sales. If the Company or any
         Subsidiary thereof, as applicable, at any time while this Warrant is
         outstanding, shall offer, sell, grant any option to purchase or offer,
         sell or grant any right to reprice its securities, or otherwise dispose
         of or issue (or announce any offer, sale, grant or any option to
         purchase or other disposition) any Common Stock or Common Stock
         Equivalents entitling any Person to acquire shares of Common Stock, at

                                       6
<PAGE>

         an effective price per share less than the then Exercise Price (such
         lower price, the "Base Share Price" and such issuances collectively, a
         "Dilutive Issuance"), as adjusted hereunder (if the holder of the
         Common Stock or Common Stock Equivalents so issued shall at any time,
         whether by operation of purchase price adjustments, reset provisions,
         floating conversion, exercise or exchange prices or otherwise, or due
         to warrants, options or rights per share which is issued in connection
         with such issuance, be entitled to receive shares of Common Stock at an
         effective price per share which is less than the Exercise Price, such
         issuance shall be deemed to have occurred for less than the Exercise
         Price on such date of the Dilutive Issuance), then the Exercise Price
         shall be reduced and only reduced to equal the Base Share Price and the
         number of Warrant Shares issuable hereunder shall be increased such
         that the aggregate Exercise Price payable hereunder, after taking into
         account the decrease in the Exercise Price, shall be equal to the
         aggregate Exercise Price prior to such adjustment. Such adjustment
         shall be made whenever such Common Stock or Common Stock Equivalents
         are issued. Notwithstanding the foregoing, no adjustments shall be
         made, paid or issued under this Section 3(b) in respect of an Exempt
         Issuance. The Company shall notify the Holder in writing, no later than
         the Trading Day following the issuance of any Common Stock or Common
         Stock Equivalents subject to this section, indicating therein the
         applicable issuance price, or of applicable reset price, exchange
         price, conversion price and other pricing terms (such notice the
         "Dilutive Issuance Notice"). For purposes of clarification, whether or
         not the Company provides a Dilutive Issuance Notice pursuant to this
         Section 3(b), upon the occurrence of any Dilutive Issuance, after the
         date of such Dilutive Issuance the Holder is entitled to receive a
         number of Warrant Shares based upon the Base Share Price regardless of
         whether the Holder accurately refers to the Base Share Price in the
         Notice of Exercise.

                  c)       Pro Rata Distributions. If the Company, at any time
         prior to the Termination Date, shall distribute to all holders of
         Common Stock (and not to Holders of the Warrants) evidences of its
         indebtedness or assets (including cash and cash dividends) or rights or
         warrants to subscribe for or purchase any security other than the
         Common Stock (which shall be subject to Section 3(b)), then in each
         such case the Exercise Price shall be adjusted by multiplying the
         Exercise Price in effect immediately prior to the record date fixed for
         determination of stockholders entitled to receive such distribution by
         a fraction of which the denominator shall be the VWAP determined as of
         the record date mentioned above, and of which the numerator shall be
         such VWAP on such record date less the then per share fair market value
         at such record date of the portion of such assets or evidence of
         indebtedness so distributed applicable to one outstanding share of the
         Common Stock as determined by the Board of Directors in good faith. In
         either case the adjustments shall be described in a statement provided
         to the Holder of the portion of assets or evidences of indebtedness so
         distributed or such subscription rights applicable to one share of
         Common Stock. Such adjustment shall be made whenever any such
         distribution is made and shall become effective immediately after the
         record date mentioned above.

                  d)       Fundamental Transaction. If, at any time while this
         Warrant is outstanding, (A) the Company effects any merger or
         consolidation of the Company with or into another Person, (B) the
         Company effects any sale of all or substantially all of its assets in

                                       7
<PAGE>

         one or a series of related transactions, (C) any tender offer or
         exchange offer (whether by the Company or another Person) is completed
         pursuant to which holders of Common Stock are permitted to tender or
         exchange their shares for other securities, cash or property, or (D)
         the Company effects any reclassification of the Common Stock or any
         compulsory share exchange pursuant to which the Common Stock is
         effectively converted into or exchanged for other securities, cash or
         property (in any such case, a "Fundamental Transaction"), then, upon
         any subsequent exercise of this Warrant, the Holder shall have the
         right to receive, for each Warrant Share that would have been issuable
         upon such exercise immediately prior to the occurrence of such
         Fundamental Transaction, at the option of the Holder, (a) upon exercise
         of this Warrant, the number of shares of Common Stock of the successor
         or acquiring corporation or of the Company, if it is the surviving
         corporation, and any additional consideration (the "Alternate
         Consideration") receivable upon or as a result of such reorganization,
         reclassification, merger, consolidation or disposition of assets by a
         Holder of the number of shares of Common Stock for which this Warrant
         is exercisable immediately prior to such event or (b) if the Company is
         acquired in an all cash transaction, cash equal to the value of this
         Warrant as determined in accordance with the Black-Scholes option
         pricing formula. For purposes of any such exercise, the determination
         of the Exercise Price shall be appropriately adjusted to apply to such
         Alternate Consideration based on the amount of Alternate Consideration
         issuable in respect of one share of Common Stock in such Fundamental
         Transaction, and the Company shall apportion the Exercise Price among
         the Alternate Consideration in a reasonable manner reflecting the
         relative value of any different components of the Alternate
         Consideration. If holders of Common Stock are given any choice as to
         the securities, cash or property to be received in a Fundamental
         Transaction, then the Holder shall be given the same choice as to the
         Alternate Consideration it receives upon any exercise of this Warrant
         following such Fundamental Transaction. To the extent necessary to
         effectuate the foregoing provisions, any successor to the Company or
         surviving entity in such Fundamental Transaction shall issue to the
         Holder a new warrant consistent with the foregoing provisions and
         evidencing the Holder's right to exercise such warrant into Alternate
         Consideration. The terms of any agreement pursuant to which a
         Fundamental Transaction is effected shall include terms requiring any
         such successor or surviving entity to comply with the provisions of
         this Section 3(d) and insuring that this Warrant (or any such
         replacement security) will be similarly adjusted upon any subsequent
         transaction analogous to a Fundamental Transaction.

                  e)       Calculations. All calculations under this Section 3
         shall be made to the nearest cent or the nearest 1/100th of a share, as
         the case may be. For purposes of this Section 3, the number of shares
         of Common Stock deemed to be issued and outstanding as of a given date
         shall be the sum of the number of shares of Common Stock (excluding
         treasury shares, if any) issued and outstanding.

                  f)       Voluntary Adjustment By Company. The Company may at
         any time during the term of this Warrant reduce the then current
         Exercise Price to any amount and for any period of time deemed
         appropriate by the Board of Directors of the Company.

                  g)       Notice to Holders.
                           -----------------

                                       8
<PAGE>

                           i.       Adjustment to Exercise Price. Whenever the
                  Exercise Price is adjusted pursuant to this Section 3, the
                  Company shall promptly mail to each Holder a notice setting
                  forth the Exercise Price after such adjustment and setting
                  forth a brief statement of the facts requiring such
                  adjustment. If the Company issues a variable rate security,
                  despite the prohibition thereon in the Purchase Agreement, the
                  Company shall be deemed to have issued Common Stock or Common
                  Stock Equivalents at the lowest possible conversion or
                  exercise price at which such securities may be converted or
                  exercised in the case of a Variable Rate Transaction (as
                  defined in the Purchase Agreement).

                           ii.       Notice to Allow Exercise by Holder. If (A)
                  the Company shall declare a dividend (or any other
                  distribution) on the Common Stock; (B) the Company shall
                  declare a special nonrecurring cash dividend on or a
                  redemption of the Common Stock; (C) the Company shall
                  authorize the granting to all holders of the Common Stock
                  rights or warrants to subscribe for or purchase any shares of
                  capital stock of any class or of any rights; (D) the approval
                  of any stockholders of the Company shall be required in
                  connection with any reclassification of the Common Stock, any
                  consolidation or merger to which the Company is a party, any
                  sale or transfer of all or substantially all of the assets of
                  the Company, of any compulsory share exchange whereby the
                  Common Stock is converted into other securities, cash or
                  property; (E) the Company shall authorize the voluntary or
                  involuntary dissolution, liquidation or winding up of the
                  affairs of the Company; then, in each case, the Company shall
                  cause to be mailed to the Holder at its last address as it
                  shall appear upon the Warrant Register of the Company, at
                  least 20 calendar days prior to the applicable record or
                  effective date hereinafter specified, a notice stating (x) the
                  date on which a record is to be taken for the purpose of such
                  dividend, distribution, redemption, rights or warrants, or if
                  a record is not to be taken, the date as of which the holders
                  of the Common Stock of record to be entitled to such dividend,
                  distributions, redemption, rights or warrants are to be
                  determined or (y) the date on which such reclassification,
                  consolidation, merger, sale, transfer or share exchange is
                  expected to become effective or close, and the date as of
                  which it is expected that holders of the Common Stock of
                  record shall be entitled to exchange their shares of the
                  Common Stock for securities, cash or other property
                  deliverable upon such reclassification, consolidation, merger,
                  sale, transfer or share exchange; provided that the failure to
                  mail such notice or any defect therein or in the mailing
                  thereof shall not affect the validity of the corporate action
                  required to be specified in such notice. The Holder is
                  entitled to exercise this Warrant during the 20-day period
                  commencing on the date of such notice to the effective date of
                  the event triggering such notice.

                                       9
<PAGE>

                  h)       Minimum Adjustment of Exercise Price. No adjustment
         of the Exercise Price shall be made in an amount of less than 1% of the
         Exercise Price in effect at the time such adjustment is otherwise
         required to be made.

         Section 4.  Transfer of Warrant.
         ---------   -------------------

                  a)       Transferability. Subject to compliance with any
         applicable securities laws and the conditions set forth in Sections
         5(a) and 4(d) hereof and to the provisions of Section 4.1 of the
         Purchase Agreement, this Warrant and all rights hereunder are
         transferable, in whole or in part, upon surrender of this Warrant at
         the principal office of the Company, together with a written assignment
         of this Warrant substantially in the form attached hereto duly executed
         by the Holder or its agent or attorney and funds sufficient to pay any
         transfer taxes payable upon the making of such transfer. Upon such
         surrender and, if required, such payment, the Company shall execute and
         deliver a new Warrant or Warrants in the name of the assignee or
         assignees and in the denomination or denominations specified in such
         instrument of assignment, and shall issue to the assignor a new Warrant
         evidencing the portion of this Warrant not so assigned, and this
         Warrant shall promptly be cancelled. A Warrant, if properly assigned,
         may be exercised by a new holder for the purchase of Warrant Shares
         without having a new Warrant issued.

                  b)       New Warrants. This Warrant may be divided or combined
         with other Warrants upon presentation hereof at the aforesaid office of
         the Company, together with a written notice specifying the names and
         denominations in which new Warrants are to be issued, signed by the
         Holder or its agent or attorney. Subject to compliance with Section
         4(a), as to any transfer which may be involved in such division or
         combination, the Company shall execute and deliver a new Warrant or
         Warrants in exchange for the Warrant or Warrants to be divided or
         combined in accordance with such notice.

                  c)       Warrant Register. The Company shall register this
         Warrant, upon records to be maintained by the Company for that purpose
         (the "Warrant Register"), in the name of the record Holder hereof from
         time to time. The Company may deem and treat the registered Holder of
         this Warrant as the absolute owner hereof for the purpose of any
         exercise hereof or any distribution to the Holder, and for all other
         purposes, absent actual notice to the contrary.

                  d)       Transfer Restrictions. If, at the time of the
         surrender of this Warrant in connection with any transfer of this
         Warrant, the transfer of this Warrant shall not be registered pursuant
         to an effective registration statement under the Securities Act and
         under applicable state securities or blue sky laws, the Company may
         require, as a condition of allowing such transfer (i) that the Holder
         or transferee of this Warrant, as the case may be, furnish to the
         Company a written opinion of counsel (which opinion shall be in form,
         substance and scope customary for opinions of counsel in comparable
         transactions) to the effect that such transfer may be made without
         registration under the Securities Act and under applicable state
         securities or blue sky laws, (ii) that the holder or transferee execute
         and deliver to the Company an investment letter in form and substance
         acceptable to the Company and (iii) that the transferee be an
         "accredited investor" as defined in Rule 501(a)(1), (a)(2), (a)(3),
         (a)(7), or (a)(8) promulgated under the Securities Act or a qualified
         institutional buyer as defined in Rule 144A(a) under the Securities
         Act.

                                       10
<PAGE>

         Section 5.  Miscellaneous.
         ---------   -------------

                  a)       Title to Warrant. Prior to the Termination Date and
         subject to compliance with applicable laws and Section 4 of this
         Warrant, this Warrant and all rights hereunder are transferable, in
         whole or in part, at the office or agency of the Company by the Holder
         in person or by duly authorized attorney, upon surrender of this
         Warrant together with the Assignment Form annexed hereto properly
         endorsed. The transferee shall sign an investment letter in form and
         substance reasonably satisfactory to the Company.

                  b)       No Rights as Shareholder Until Exercise. This Warrant
         does not entitle the Holder to any voting rights or other rights as a
         shareholder of the Company prior to the exercise hereof. Upon the
         surrender of this Warrant and the payment of the aggregate Exercise
         Price (or by means of a cashless exercise), the Warrant Shares so
         purchased shall be and be deemed to be issued to such Holder as the
         record owner of such shares as of the close of business on the later of
         the date of such surrender or payment.

                  c)       Loss, Theft, Destruction or Mutilation of Warrant.
         The Company covenants that upon receipt by the Company of evidence
         reasonably satisfactory to it of the loss, theft, destruction or
         mutilation of this Warrant or any stock certificate relating to the
         Warrant Shares, and in case of loss, theft or destruction, of indemnity
         or security reasonably satisfactory to it (which, in the case of the
         Warrant, shall not include the posting of any bond), and upon surrender
         and cancellation of such Warrant or stock certificate, if mutilated,
         the Company will make and deliver a new Warrant or stock certificate of
         like tenor and dated as of such cancellation, in lieu of such Warrant
         or stock certificate.

                  d)       Saturdays, Sundays, Holidays, etc. If the last or
         appointed day for the taking of any action or the expiration of any
         right required or granted herein shall be a Saturday, Sunday or a legal
         holiday, then such action may be taken or such right may be exercised
         on the next succeeding day not a Saturday, Sunday or legal holiday.

                  e)       Authorized Shares.
                           -----------------

                                    The Company covenants that during the period
                  the Warrant is outstanding, it will reserve from its
                  authorized and unissued Common Stock a sufficient number of
                  shares to provide for the issuance of the Warrant Shares upon
                  the exercise of any purchase rights under this Warrant. The
                  Company further covenants that its issuance of this Warrant
                  shall constitute full authority to its officers who are
                  charged with the duty of executing stock certificates to
                  execute and issue the necessary certificates for the Warrant
                  Shares upon the exercise of the purchase rights under this
                  Warrant. The Company will take all such reasonable action as
                  may be necessary to assure that such Warrant Shares may be
                  issued as provided herein without violation of any applicable
                  law or regulation, or of any requirements of the Trading
                  Market upon which the Common Stock may be listed.

                                       11
<PAGE>

                                    Except and to the extent as waived or
                  consented to by the Holder, the Company shall not by any
                  action, including, without limitation, amending its
                  certificate of incorporation or through any reorganization,
                  transfer of assets, consolidation, merger, dissolution, issue
                  or sale of securities or any other voluntary action, avoid or
                  seek to avoid the observance or performance of any of the
                  terms of this Warrant, but will at all times in good faith
                  assist in the carrying out of all such terms and in the taking
                  of all such actions as may be necessary or appropriate to
                  protect the rights of Holder as set forth in this Warrant
                  against impairment. Without limiting the generality of the
                  foregoing, the Company will (a) not increase the par value of
                  any Warrant Shares above the amount payable therefor upon such
                  exercise immediately prior to such increase in par value, (b)
                  take all such action as may be necessary or appropriate in
                  order that the Company may validly and legally issue fully
                  paid and nonassessable Warrant Shares upon the exercise of
                  this Warrant, and (c) use commercially reasonable efforts to
                  obtain all such authorizations, exemptions or consents from
                  any public regulatory body having jurisdiction thereof as may
                  be necessary to enable the Company to perform its obligations
                  under this Warrant.

                                    Before taking any action which would result
                  in an adjustment in the number of Warrant Shares for which
                  this Warrant is exercisable or in the Exercise Price, the
                  Company shall obtain all such authorizations or exemptions
                  thereof, or consents thereto, as may be necessary from any
                  public regulatory body or bodies having jurisdiction thereof.

                  f)       Jurisdiction. All questions concerning the
         construction, validity, enforcement and interpretation of this Warrant
         shall be determined in accordance with the provisions of the Purchase
         Agreement.

                  g)       Restrictions. The Holder acknowledges that the
         Warrant Shares acquired upon the exercise of this Warrant, if not
         registered, will have restrictions upon resale imposed by state and
         federal securities laws.

                  h)       Nonwaiver and Expenses. No course of dealing or any
         delay or failure to exercise any right hereunder on the part of Holder
         shall operate as a waiver of such right or otherwise prejudice Holder's
         rights, powers or remedies, notwithstanding the fact that all rights
         hereunder terminate on the Termination Date. If the Company willfully
         and knowingly fails to comply with any provision of this Warrant, which
         results in any material damages to the Holder, the Company shall pay to
         Holder such amounts as shall be sufficient to cover any costs and
         expenses including, but not limited to, reasonable attorneys' fees,
         including those of appellate proceedings, incurred by Holder in
         collecting any amounts due pursuant hereto or in otherwise enforcing
         any of its rights, powers or remedies hereunder.

                                       12
<PAGE>

                  i)       Notices. Any notice, request or other document
         required or permitted to be given or delivered to the Holder by the
         Company shall be delivered in accordance with the notice provisions of
         the Purchase Agreement.

                  j)       Limitation of Liability. No provision hereof, in the
         absence of any affirmative action by Holder to exercise this Warrant or
         purchase Warrant Shares, and no enumeration herein of the rights or
         privileges of Holder, shall give rise to any liability of Holder for
         the purchase price of any Common Stock or as a stockholder of the
         Company, whether such liability is asserted by the Company or by
         creditors of the Company.

                  k)       Remedies. Holder, in addition to being entitled to
         exercise all rights granted by law, including recovery of damages, will
         be entitled to specific performance of its rights under this Warrant.
         The Company agrees that monetary damages would not be adequate
         compensation for any loss incurred by reason of a breach by it of the
         provisions of this Warrant and hereby agrees to waive the defense in
         any action for specific performance that a remedy at law would be
         adequate.

                  l)       Successors and Assigns. Subject to applicable
         securities laws, this Warrant and the rights and obligations evidenced
         hereby shall inure to the benefit of and be binding upon the successors
         of the Company and the successors and permitted assigns of Holder. The
         provisions of this Warrant are intended to be for the benefit of all
         Holders from time to time of this Warrant and shall be enforceable by
         any such Holder or holder of Warrant Shares.

                  m)       Amendment. This Warrant may be modified or amended or
         the provisions hereof waived with the written consent of the Company
         and the Holder.

                  n)       Severability. Wherever possible, each provision of
         this Warrant shall be interpreted in such manner as to be effective and
         valid under applicable law, but if any provision of this Warrant shall
         be prohibited by or invalid under applicable law, such provision shall
         be ineffective to the extent of such prohibition or invalidity, without
         invalidating the remainder of such provisions or the remaining
         provisions of this Warrant.

                  o)       Headings. The headings used in this Warrant are for
         the convenience of reference only and shall not, for any purpose, be
         deemed a part of this Warrant.

                              ********************

                                       13
<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be executed
by its officer thereunto duly authorized.

Dated:  October 27, 2005

                                       VELOCITY ASSET MANAGEMENT INC.

                                       By:______________________________________
                                          Name:
                                          Title:

                                       14
<PAGE>

                               NOTICE OF EXERCISE

TO:         [_______________________

         (1)_________The undersigned hereby elects to purchase ________ Warrant
Shares of the Company pursuant to the terms of the attached Warrant (only if
exercised in full), and tenders herewith payment of the exercise price in full,
together with all applicable transfer taxes, if any.

         (2)_________Payment shall take the form of (check applicable box):

                           [ ] in lawful money of the United States; or

                           [ ] the cancellation of such number of Warrant Shares
                           as is necessary, in accordance with the formula set
                           forth in subsection 2(c), to exercise this Warrant
                           with respect to the maximum number of Warrant Shares
                           purchasable pursuant to the cashless exercise
                           procedure set forth in subsection 2(c).

         (3)_________Please issue a certificate or certificates representing
said Warrant Shares in the name of the undersigned or in such other name as is
specified below:

                           _________________________________________

The Warrant Shares shall be delivered to the following:

                           _________________________________________

                           _________________________________________

                           _________________________________________

         (4) Accredited Investor. The undersigned is an "accredited investor" as
defined in Regulation D promulgated under the Securities Act of 1933, as
amended.

[SIGNATURE OF HOLDER]

Name of Investing Entity: ______________________________________________________

Signature of Authorized Signatory of Investing Entity: _________________________

Name of Authorized Signatory: __________________________________________________

Title of Authorized Signatory: _________________________________________________

Date: __________________________________________________________________________

<PAGE>

                                 ASSIGNMENT FORM

                    (To assign the foregoing warrant, execute
                   this form and supply required information.
                 Do not use this form to exercise the warrant.)

         FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced
thereby are hereby assigned to

_______________________________________________ whose address is

__________________________________________________________________________.

__________________________________________________________________________

                                           Dated:  ______________, _______

                 Holder's Signature:     _____________________________

                 Holder's Address:       _____________________________

                                         _____________________________

Signature Guaranteed:  ___________________________________________

NOTE: The signature to this Assignment Form must correspond with the name as it
appears on the face of the Warrant, without alteration or enlargement or any
change whatsoever, and must be guaranteed by a bank or trust company. Officers
of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.EXHIBIT 10.1

                          SECURITIES PURCHASE AGREEMENT

     This Securities Purchase Agreement (this "Agreement") is dated as of
October 27, 2005 among Velocity Asset Management Inc., a Delaware corporation
(the "Company"), J. Holder Inc., a New Jersey corporation (the "Subsidiary", and
the Company and Subsidiary, collectively, the "Borrowers") and each purchaser
identified on the signature pages hereto (each, including its successors and
assigns, a "Purchaser" and collectively the "Purchasers").

     WHEREAS, subject to the terms and conditions set forth in this Agreement
and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the
"Securities Act") and Rule 506 promulgated thereunder, the Borrowers desire to
issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
desires to purchase from the Borrowers, in the aggregate, up to $3,000,000 of
Debentures and Warrants, as more fully described in this Agreement.

     NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this
Agreement, and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the Borrowers and each Purchaser
agree as follows:

                                   ARTICLE I.
                                   DEFINITIONS

     1.1 Definitions. In addition to the terms defined elsewhere in this
Agreement: (a) capitalized terms that are not otherwise defined herein have the
meanings given to such terms in the Debentures (as defined herein), and (b) the
following terms have the meanings indicated in this Section 1.1:

          "Action" shall have the meaning ascribed to such term in Section
     3.1(j).

          "Affiliate" means any Person that, directly or indirectly through one
     or more intermediaries, controls or is controlled by or is under common
     control with a Person, as such terms are used in and construed under Rule
     144 under the Securities Act. With respect to a Purchaser, any investment
     fund or managed account that is managed on a discretionary basis by the
     same investment manager as such Purchaser will be deemed to be an Affiliate
     of such Purchaser.

          "Closing" means the closing of the purchase and sale of the Securities
     pursuant to Section 2.1.

          "Closing Date" means the Trading Day when all of the Transaction
     Documents have been executed and delivered by the applicable parties
     thereto, and all conditions precedent to (i) the Purchasers' obligations to
     pay the Subscription Amount and (ii) the Borrowers' obligations to deliver
     the Securities have been satisfied or waived.

<PAGE>

          "Closing Price" means on any particular date (a) the last reported
     closing bid price per share of Common Stock on such date on the Trading
     Market (as reported by Bloomberg L.P. at 4:15 PM (New York time), or (b) if
     there is no such price on such date, then the closing bid price on the
     Trading Market on the date nearest preceding such date (as reported by
     Bloomberg L.P. at 4:15 PM (New York time) for the closing bid price for
     regular session trading on such day), or (c) if the Common Stock is not
     then listed or quoted on the Trading Market and if prices for the Common
     Stock are then reported in the "pink sheets" published by the National
     Quotation Bureau Incorporated (or a similar organization or agency
     succeeding to its functions of reporting prices), the most recent bid price
     per share of the Common Stock so reported, or (d) if the shares of Common
     Stock are not then publicly traded the fair market value of a share of
     Common Stock as determined by a qualified independent appraiser selected in
     good faith by the Purchasers of a majority in interest of the Securities
     then outstanding.

          "Commission" means the Securities and Exchange Commission.

          "Common Stock" means the common stock of the Company, par value $.001
     per share, and any other class of securities into which such securities may
     hereafter have been reclassified or changed into.

          "Common Stock Equivalents" means any securities of the Borrowers or
     the Subsidiaries which would entitle the holder thereof to acquire at any
     time Common Stock, including, without limitation, any debt, preferred
     stock, rights, options, warrants or other instrument that is at any time
     convertible into or exercisable or exchangeable for, or otherwise entitles
     the holder thereof to receive, Common Stock.

          "Borrowers Counsel" means Ellenoff, Grossman & Schole, LLP.

          "Conversion Price" shall have the meaning ascribed to such term in the
     Debentures.

          "Debentures" means, the 10% Convertible Secured Debentures due,
     subject to the terms therein, 18 months from their date of issuance, issued
     by the Borrowers, jointly and severally, to the Purchasers hereunder, in
     the form of Exhibit A.

          "Disclosure Schedules" shall have the meaning ascribed to such term in
     Section 3.1.

          "Effective Date" means the date that the initial Registration
     Statement filed by the Company pursuant to the Registration Rights
     Agreement is first declared effective by the Commission.

          "Evaluation Date" shall have the meaning ascribed to such term in
     Section 3.1(r).

          "Exchange Act" means the Securities Exchange Act of 1934, as amended,
     and the rules and regulations promulgated thereunder.

                                       2
<PAGE>

          "Exempt Issuance" means the issuance of (a) shares of Common Stock or
     options to employees, officers or directors of the Company pursuant to any
     stock or option plan in existence on the date hereof or duly adopted by a
     majority of the Board of Directors of the Company, (b) securities upon the
     exercise or exchange of or conversion of any Securities issued hereunder
     and/or securities exercisable or exchangeable for or convertible into
     shares of Common Stock issued and outstanding on the date of this
     Agreement, provided that such securities have not been amended since the
     date of this Agreement to increase the number of such securities or to
     decrease the exercise, exchange or conversion price of any such securities,
     and (c) securities issued pursuant to acquisitions or strategic
     transactions (including, but not limited to, the acquisition of licenses,
     sublicenses, intellectual property or proprietary rights), provided any
     such issuance shall only be to a Person which is, itself or through its
     subsidiaries, an operating company in a business synergistic with the
     business of the Borrowers and in which the Borrowers receive benefits in
     addition to the investment of funds, but shall not include a transaction in
     which the Company is issuing securities primarily for the purpose of
     raising capital or to an entity whose primary business is investing in
     securities.

          "FW" means Feldman Weinstein LLP with offices located at 420 Lexington
     Avenue, Suite 2620, New York, New York 10170-0002.

          "GAAP" shall have the meaning ascribed to such term in Section 3.1(h).

          "Intellectual Property Rights" shall have the meaning ascribed to such
     term in Section 3.1(o).

          "Legend Removal Date" shall have the meaning ascribed to such term in
     Section 4.1(c).

          "Liens" means a lien, charge, security interest, encumbrance, right of
     first refusal, preemptive right or other restriction.

          "Material Adverse Effect" shall have the meaning assigned to such term
     in Section 3.1(b).

          "Material Permits" shall have the meaning ascribed to such term in
     Section 3.1(m).

          "Maximum Rate" shall have the meaning ascribed to such term in Section
     5.17.

          "Participation Maximum" shall have the meaning ascribed to such term
     in Section 4.13.

          "Person" means an individual or corporation, partnership, trust,
     incorporated or unincorporated association, joint venture, limited
     liability company, joint stock company, government (or an agency or
     subdivision thereof) or other entity of any kind.

                                       3
<PAGE>

          "Pre-Notice" shall have the meaning ascribed to such term in Section
     4.13.

          "Proceeding" means an action, claim, suit, investigation or proceeding
     (including, without limitation, an investigation or partial proceeding,
     such as a deposition) actually commenced or as to the threat of which the
     Company has actual knowledge

          "Purchaser Party" shall have the meaning ascribed to such term in
     Section 4.11.

          "Registration Rights Agreement" means the Registration Rights
     Agreement, dated the date hereof, among the Company and the Purchasers, in
     the form of Exhibit B attached hereto.

          "Registration Statement" means a registration statement meeting the
     requirements set forth in the Registration Rights Agreement and covering
     the resale of the Underlying Shares by each Purchaser as provided for in
     the Registration Rights Agreement.

          "Required Approvals" shall have the meaning ascribed to such term in
     Section 3.1(e).

          "Required Minimum" means, as of any date, the maximum aggregate number
     of shares of Common Stock then issued or potentially issuable in the future
     pursuant to the Transaction Documents, including any Underlying Shares
     issuable upon exercise or conversion in full of all Warrants and Debentures
     (including Underlying Shares issuable as payment of interest), ignoring any
     conversion or exercise limits set forth therein, and assuming that the
     Conversion Price is at all times on and after the date of determination 75%
     of the then Conversion Price on the Trading Day immediately prior to the
     date of determination.

          "Rule 144" means Rule 144 promulgated by the Commission pursuant to
     the Securities Act, as such Rule may be amended from time to time, or any
     similar rule or regulation hereafter adopted by the Commission having
     substantially the same effect as such Rule.

          "SEC Reports" shall have the meaning ascribed to such term in Section
     3.1(h).

          "Secondary Offering" means a public offering of preferred stock of the
     Company or Common Stock by the Company of up to $10,000,000 to be
     consummated pursuant to the initial Registration Statement in a best
     efforts underwritten offering.

          "Securities" means the Debentures, the Warrants, the Warrant Shares
     and the Underlying Shares.

          "Securities Act" means the Securities Act of 1933, as amended.

          "Security Agreement" means the Security Agreement, dated the date
     hereof, among the Company and the Purchasers, in the form of Exhibit E
     attached hereto.

                                       4
<PAGE>

          "Security Documents" shall mean the Security Agreement, the Subsidiary
     Guarantees and any other documents and filing required thereunder in order
     to grant the Purchasers a first priority security interest in the assets of
     the Company as provided in the Security Agreement, including all UCC-1
     filing receipts.

          "Short Sales" shall include all "short sales" as defined in Rule 200
     of Regulation SHO under the Exchange Act.

          "Subscription Amount" means, as to each Purchaser, the aggregate
     amount to be paid for Debentures and Warrants purchased hereunder as
     specified below such Purchaser's name on the signature page of this
     Agreement and next to the heading "Subscription Amount", in United States
     Dollars and in immediately available funds.

          "Subsequent Financing" shall have the meaning ascribed to such term in
     Section 4.13.

          "Subsequent Financing Notice" shall have the meaning ascribed to such
     term in Section 4.13.

          "Subsidiary" means any subsidiary of the Company as set forth on
     Schedule 3.1(a).

          "Subsidiary Guarantee" means the Subsidiary Guarantee, dated the date
     hereof, among each of its Subsidiaries, other than Velocity Investments,
     LLC, and the Purchasers, in the form of Exhibit F attached hereto.

          "Trading Day" means a day on which the Common Stock is traded on a
     Trading Market.

          "Trading Market" means any of the following markets or exchanges on
     which the Common Stock is listed or quoted for trading on the date in
     question: the Nasdaq Capital Market, the American Stock Exchange, the New
     York Stock Exchange, the Nasdaq National Market or OTC Bulletin Board.

          "Transaction Documents" means this Agreement, the Debentures, the
     Warrants, the Security Agreement, the Registration Rights Agreement and any
     other documents or agreements executed in connection with the transactions
     contemplated hereunder.

          "Underlying Shares" means the shares of Common Stock issued and
     issuable upon conversion of the Debentures and upon exercise of the
     Warrants and issued and issuable in lieu of the cash payment of interest on
     the Debentures in accordance with the terms of the Debentures.

          "Warrants" means collectively the Common Stock purchase warrants, in
     the form of Exhibit C delivered to the Purchasers at the Closing in
     accordance with Section 2.2(a) hereof, which Warrants shall be exercisable
     beginning 6 months following the date hereof and have a term of exercise
     equal to 5 years.

                                       5
<PAGE>

          "Warrant Shares" means the shares of Common Stock issuable upon
     exercise of the Warrants.

                                   ARTICLE II.
                                PURCHASE AND SALE

     2.1 Closing. On the Closing Date, upon the terms and subject to the
conditions set forth herein, concurrent with the execution and delivery of this
Agreement by the parties hereto, the Borrowers agree to sell, jointly and
severally, and each Purchaser agrees to purchase in the aggregate, severally and
not jointly, up to $3,000,000 principal amount of the Debentures. Each Purchaser
shall deliver to the designated Borrower via wire transfer or a certified check
immediately available funds equal to their Subscription Amount and the Borrowers
shall deliver to each Purchaser their respective Debenture and Warrants as
determined pursuant to Section 2.2(a) and the other items set forth in Section
2.2 issuable at the Closing. Upon satisfaction of the conditions set forth in
Sections 2.2 and 2.3, the Closing shall occur at the offices of FW, or such
other location as the parties shall mutually agree.

     2.2 Deliveries.

          (a) On the Closing Date, the Borrowers, as applicable, shall deliver
     or cause to be delivered to each Purchaser the following:

               (i) this Agreement duly executed by each Borrower;

               (ii) a legal opinion of Borrowers' Counsel, in the form of
          Exhibit D attached hereto;

               (iii) a Debenture with a principal amount equal to such
          Purchaser's Subscription Amount, registered in the name of such
          Purchaser;

               (iv) a Warrant registered in the name of such Purchaser to
          purchase up to 200,000 shares of Common Stock for each $1 million of
          Subscription Amount of such Purchaser (pro-rated for fractional
          Subscription Amounts), with an exercise price equal to $3.10 subject
          to adjustment therein;

               (v) a notarized Personal Guarantee, duly executed by Jack
          Kleinert, Peter Ragan Sr. and Peter Ragan Jr. in favor of the
          Purchasers, in the form of Exhibit G attached hereto;

               (vi) the Security Agreement, duly executed by the Company, along
          with all the Security Documents duly executed by the parties thereto,
          including the Subsidiary Guarantee; and

               (vii) the Registration Rights Agreement duly executed by the
          Company.

          (b) On the Closing Date, each Purchaser shall deliver or cause to be
     delivered to the Borrowers the following:

                                       6
<PAGE>

               (i) this Agreement duly executed by such Purchaser;

               (ii) such Purchaser's Subscription Amount by wire transfer to the
          account as specified in writing by the Borrowers; and

               (iii) the Registration Rights Agreement, duly executed by such
          Purchaser.

     2.3 Closing Conditions.

          (a) The obligations of the Borrowers hereunder in connection with the
     Closing are subject to the following conditions being met:

               (i) the accuracy in all material respects when made and on the
          Closing Date of the representations and warranties of the Purchasers
          contained herein;

               (ii) all obligations, covenants and agreements of the Purchasers
          required to be performed at or prior to the Closing Date shall have
          been performed; and

               (iii) the delivery by the Purchasers of the items set forth in
          Section 2.2(b) of this Agreement including, without limitation,
          Subscription Amounts in the aggregate of $3,000,000.

          (b) The respective obligations of the Purchasers hereunder in
     connection with the Closing are subject to the following conditions being
     met:

               (i) the accuracy in all material respects on the Closing Date of
          the representations and warranties of the Borrowers contained herein;

               (ii) all obligations, covenants and agreements of the Borrowers
          required to be performed at or prior to the Closing Date shall have
          been performed;

               (iii) the delivery by the Borrowers, as applicable, of the items
          set forth in Section 2.2(a) of this Agreement;

               (iv) there shall have been no Material Adverse Effect with
          respect to either Borrower since the date hereof; and

               (v) from the date hereof to the Closing Date, trading in the
          Common Stock shall not have been suspended by the Commission (except
          for any suspension of trading of limited duration agreed to by the
          Company, which suspension shall be terminated prior to the Closing),
          and, at any time prior to the Closing Date, trading in securities
          generally as reported by Bloomberg Financial Markets shall not have
          been suspended or limited, or minimum prices shall not have been
          established on securities whose trades are reported by such service,
          or

                                       7
<PAGE>

          on any Trading Market, nor shall a banking moratorium have been
          declared either by the United States or New York State authorities nor
          shall there have occurred any material outbreak or escalation of
          hostilities or other national or international calamity of such
          magnitude in its effect on, or any material adverse change in, any
          financial market which, in each case, in the reasonable judgment of
          each Purchaser, makes it impracticable or inadvisable to purchase the
          Debentures at the Closing.

                                  ARTICLE III.
                         REPRESENTATIONS AND WARRANTIES

     3.1 Representations and Warranties of the Borrowers. Except as set forth
under the corresponding section of the disclosure schedules delivered to the
Purchasers concurrently herewith (the "Disclosure Schedules") which Disclosure
Schedules shall be deemed a part hereof, the Borrowers, jointly and severally,
hereby make the representations and warranties set forth below to each
Purchaser.

          (a) Subsidiaries. All of the direct and indirect subsidiaries of the
     Borrowers are set forth on Schedule 3.1(a). The Borrowers own, directly or
     indirectly, all of the capital stock or other equity interests of each
     Subsidiary free and clear of any Liens, and all the issued and outstanding
     shares of capital stock of each Subsidiary are validly issued and are fully
     paid, non-assessable and free of preemptive and similar rights to subscribe
     for or purchase securities.

          (b) Organization and Qualification. The Borrowers and each of the
     Subsidiaries is an entity duly incorporated or otherwise organized, validly
     existing and in good standing under the laws of the jurisdiction of its
     incorporation or organization (as applicable), with the requisite power and
     authority to own and use its properties and assets and to carry on its
     business as currently conducted. Neither the Borrowers nor any Subsidiary
     is in violation or default of any of the provisions of its respective
     certificate or articles of incorporation, bylaws or other organizational or
     charter documents. Each of the Borrowers and the Subsidiaries is duly
     qualified to conduct business and is in good standing as a foreign
     corporation or other entity in each jurisdiction in which the nature of the
     business conducted or property owned by it makes such qualification
     necessary, except where the failure to be so qualified or in good standing,
     as the case may be, could not have or reasonably be expected to result in
     (i) a material adverse effect on the legality, validity or enforceability
     of any Transaction Document, (ii) a material adverse effect on the results
     of operations, assets, business, prospects or condition (financial or
     otherwise) of the Borrowers and the Subsidiaries, taken as a whole, or
     (iii) a material adverse effect on the Borrowers' ability to perform in any
     material respect on a timely basis its obligations under any Transaction
     Document (any of (i), (ii) or (iii), a "Material Adverse Effect") and no
     Proceeding has been instituted in any such jurisdiction revoking, limiting
     or curtailing or seeking to revoke, limit or curtail such power and
     authority or qualification.

                                       8
<PAGE>

          (c) Authorization; Enforcement. The Borrowers have the requisite
     corporate power and authority to enter into and to consummate the
     transactions contemplated by each of the Transaction Documents and
     otherwise to carry out its obligations hereunder and thereunder. The
     execution and delivery of each of the Transaction Documents by the
     Borrowers and the consummation by it of the transactions contemplated
     thereby have been duly authorized by all necessary action on the part of
     the Borrowers and no further action is required by the Borrowers, its board
     of directors or its stockholders in connection therewith other than in
     connection with the Required Approvals. Each applicable Transaction
     Document has been (or upon delivery will have been) duly executed by the
     Borrowers and, when delivered in accordance with the terms hereof and
     thereof, will constitute the valid and binding obligation of the Borrowers
     enforceable against each Borrower in accordance with its terms except (i)
     as limited by applicable bankruptcy, insolvency, reorganization, moratorium
     and other laws of general application affecting enforcement of creditors'
     rights generally, (ii) as limited by laws relating to the availability of
     specific performance, injunctive relief or other equitable remedies and
     (iii) as limited by federal and state laws or the public policy underlying
     such laws with respect to indemnity or contribution.

          (d) No Conflicts. The execution, delivery and performance of the
     Transaction Documents by the Borrowers and the consummation by the
     Borrowers of the other transactions contemplated hereby and thereby do not
     and will not: (i) conflict with or violate any provision of the Borrowers'
     or any Subsidiary's certificate or articles of incorporation, bylaws or
     other organizational or charter documents, or (ii) conflict with, or
     constitute a default (or an event that with notice or lapse of time or both
     would become a default) under, result in the creation of any Lien upon any
     of the properties or assets of the Borrowers or any Subsidiary, or give to
     others any rights of termination, amendment, acceleration or cancellation
     (with or without notice, lapse of time or both) of, any agreement, credit
     facility, debt or other instrument (evidencing a Borrower or Subsidiary
     debt or otherwise) or other understanding to which the Borrowers or any
     Subsidiary is a party or by which any property or asset of the Borrowers or
     any Subsidiary is bound or affected, or (iii) subject to the Required
     Approvals, conflict with or result in a violation of any law, rule,
     regulation, order, judgment, injunction, decree or other restriction of any
     court or governmental authority to which the Borrowers or a Subsidiary is
     subject (including federal and state securities laws and regulations), or
     by which any property or asset of the Borrowers or a Subsidiary is bound or
     affected; except in the case of each of clauses (ii) and (iii), such as
     could not have or reasonably be expected to result in a Material Adverse
     Effect.

          (e) Filings, Consents and Approvals. The Borrowers are not required to
     obtain any consent, waiver, authorization or order of, give any notice to,
     or make any filing or registration with, any court or other federal, state,
     local or other governmental authority or other Person in connection with
     the execution, delivery and performance by the Borrowers of the Transaction
     Documents, other than (i) filings required pursuant to Section 4.6, (ii)
     the filing with the Commission of the Registration Statement, (iii) the
     notice and/or application(s) to each applicable Trading Market for the
     issuance and sale of the Debentures and Warrants and the listing of the
     Underlying Shares for trading

                                       9
<PAGE>

     thereon in the time and manner required thereby and (iv) the filing of Form
     D with the Commission and such filings as are required to be made under
     applicable state securities laws (collectively, the "Required Approvals").

          (f) Issuance of the Securities. The Securities are duly authorized
     and, when issued and paid for in accordance with the applicable Transaction
     Documents, will be duly and validly issued, fully paid and nonassessable,
     free and clear of all Liens imposed by the Borrowers other than
     restrictions on transfer provided for in the Transaction Documents. The
     Underlying Shares, when issued in accordance with the terms of the
     Transaction Documents, will be validly issued, fully paid and
     nonassessable, free and clear of all Liens imposed by the Company. The
     Company has reserved from its duly authorized capital stock a number of
     shares of Common Stock for issuance of the Underlying Shares at least equal
     to the Required Minimum on the date hereof.

          (g) Capitalization. The capitalization of the Company is as set forth
     on Schedule 3.1(g). The Company has not issued any capital stock since its
     most recently filed periodic report under the Exchange Act, other than
     pursuant to the exercise of employee stock options under the Company's
     stock option plans, the issuance of shares of Common Stock to employees
     pursuant to the Company's employee stock purchase plan and pursuant to the
     conversion or exercise of outstanding Common Stock Equivalents. No Person
     has any right of first refusal, preemptive right, right of participation,
     or any similar right to participate in the transactions contemplated by the
     Transaction Documents. Except as a result of the purchase and sale of the
     Securities, there are no outstanding options, warrants, script rights to
     subscribe to, calls or commitments of any character whatsoever relating to,
     or securities, rights or obligations convertible into or exercisable or
     exchangeable for, or giving any Person any right to subscribe for or
     acquire, any shares of Common Stock, or contracts, commitments,
     understandings or arrangements by which the Borrowers or any Subsidiary is
     or may become bound to issue additional shares of Common Stock or Common
     Stock Equivalents. The issuance and sale of the Securities will not
     obligate the Borrowers to issue shares of Common Stock or other securities
     to any Person (other than the Purchasers) and will not result in a right of
     any holder of Company securities to adjust the exercise, conversion,
     exchange or reset price under such securities. All of the outstanding
     shares of capital stock of the Company are validly issued, fully paid and
     nonassessable, have been issued in compliance with all federal and state
     securities laws, and none of such outstanding shares was issued in
     violation of any preemptive rights or similar rights to subscribe for or
     purchase securities. No further approval or authorization of any
     stockholder, the board of directors of either Borrower or others is
     required for the issuance and sale of the Securities. There are no
     stockholders agreements, voting agreements or other similar agreements with
     respect to the Company's capital stock to which the Company is a party or,
     to the knowledge of the Company, between or among any of the Company's
     stockholders.

          (h) SEC Reports; Financial Statements. The Company has filed all
     reports, schedules, forms, statements and other documents required to be
     filed by it under the Securities Act and the Exchange Act, including
     pursuant to Section 13(a) or 15(d)

                                       10
<PAGE>

     thereof, for the two years preceding the date hereof (or such shorter
     period as the Company was required by law to file such material) (the
     foregoing materials, including the exhibits thereto and documents
     incorporated by reference therein, being collectively referred to herein as
     the "SEC Reports") on a timely basis or has received a valid extension of
     such time of filing and has filed any such SEC Reports prior to the
     expiration of any such extension. As of their respective dates, the SEC
     Reports complied in all material respects with the requirements of the
     Securities Act and the Exchange Act and the rules and regulations of the
     Commission promulgated thereunder, and none of the SEC Reports, when filed,
     contained any untrue statement of a material fact or omitted to state a
     material fact required to be stated therein or necessary in order to make
     the statements therein, in the light of the circumstances under which they
     were made, not misleading. The financial statements of the Company included
     in the SEC Reports comply in all material respects with applicable
     accounting requirements and the rules and regulations of the Commission
     with respect thereto as in effect at the time of filing. Such financial
     statements have been prepared in accordance with United States generally
     accepted accounting principles applied on a consistent basis during the
     periods involved ("GAAP"), except as may be otherwise specified in such
     financial statements or the notes thereto and except that unaudited
     financial statements may not contain all footnotes required by GAAP, and
     fairly present in all material respects the financial position of the
     Company and its consolidated subsidiaries as of and for the dates thereof
     and the results of operations and cash flows for the periods then ended,
     subject, in the case of unaudited statements, to normal, immaterial,
     year-end audit adjustments.

          (i) Material Changes. Since the date of the latest audited financial
     statements included within the SEC Reports, except as specifically
     disclosed in the SEC Reports, (i) there has been no event, occurrence or
     development that has had or that could reasonably be expected to result in
     a Material Adverse Effect, (ii) the Borrowers have not incurred any
     liabilities (contingent or otherwise) other than (A) trade payables and
     accrued expenses incurred in the ordinary course of business consistent
     with past practice and (B) liabilities not required to be reflected in the
     Company's financial statements pursuant to GAAP or required to be disclosed
     in filings made with the Commission, (iii) the Company has not altered its
     method of accounting, (iv) the Company has not declared or made any
     dividend or distribution of cash or other property to its stockholders or
     purchased, redeemed or made any agreements to purchase or redeem any shares
     of its capital stock and (v) the Company has not issued any equity
     securities to any officer, director or Affiliate, except pursuant to
     existing Company stock option plans. The Company does not have pending
     before the Commission any request for confidential treatment of
     information.

          (j) Litigation. There is no action, suit, inquiry, notice of
     violation, proceeding or investigation pending or, to the knowledge of the
     Borrowers, threatened against or affecting the Borrowers, any Subsidiary or
     any of their respective properties before or by any court, arbitrator,
     governmental or administrative agency or regulatory authority (federal,
     state, county, local or foreign) (collectively, an "Action") which (i)
     adversely affects or challenges the legality, validity or enforceability of
     any of the Transaction Documents or the Securities or (ii) could, if there
     were an unfavorable decision, have or

                                       11
<PAGE>

     reasonably be expected to result in a Material Adverse Effect. Neither the
     Borrowers nor any Subsidiary, nor any director or officer thereof, is or
     has been the subject of any Action involving a claim of violation of or
     liability under federal or state securities laws or a claim of breach of
     fiduciary duty. There has not been, and to the knowledge of the Company,
     there is not pending or contemplated, any investigation by the Commission
     involving the Company or any current or former director or officer of the
     Company. The Commission has not issued any stop order or other order
     suspending the effectiveness of any registration statement filed by the
     Company or any Subsidiary under the Exchange Act or the Securities Act.

          (k) Labor Relations. No material labor dispute exists or, to the
     knowledge of the Borrowers, is imminent with respect to any of the
     employees of the Borrowers which could reasonably be expected to result in
     a Material Adverse Effect.

          (l) Compliance. Neither the Borrowers nor any Subsidiary (i) is in
     default under or in violation of (and no event has occurred that has not
     been waived that, with notice or lapse of time or both, would result in a
     default by the Borrowers or any Subsidiary under), nor has the Borrowers or
     any Subsidiary received notice of a claim that it is in default under or
     that it is in violation of, any indenture, loan or credit agreement or any
     other agreement or instrument to which it is a party or by which it or any
     of its properties is bound (whether or not such default or violation has
     been waived), (ii) is in violation of any order of any court, arbitrator or
     governmental body, or (iii) is or has been in violation of any statute,
     rule or regulation of any governmental authority, including without
     limitation all foreign, federal, state and local laws applicable to its
     business except in each case as could not have a Material Adverse Effect.

          (m) Regulatory Permits. The Borrowers and the Subsidiaries possess all
     certificates, authorizations and permits issued by the appropriate federal,
     state, local or foreign regulatory authorities necessary to conduct their
     respective businesses as described in the SEC Reports, except where the
     failure to possess such permits could not have or reasonably be expected to
     result in a Material Adverse Effect ("Material Permits"), and neither the
     Borrowers nor any Subsidiary has received any notice of proceedings
     relating to the revocation or modification of any Material Permit.

          (n) Title to Assets. The Borrowers and the Subsidiaries have good and
     marketable title in fee simple to all real property owned by them that is
     material to the business of the Borrowers and the Subsidiaries and good and
     marketable title in all personal property owned by them that is material to
     the business of the Borrowers and the Subsidiaries, in each case free and
     clear of all Liens, except for Liens as do not materially affect the value
     of such property and do not materially interfere with the use made and
     proposed to be made of such property by the Borrowers and the Subsidiaries
     and Liens for the payment of federal, state or other taxes, the payment of
     which is neither delinquent nor subject to penalties. Any real property and
     facilities held under lease by the Borrowers and the Subsidiaries are held
     by them under valid, subsisting and enforceable leases of which the
     Borrowers and the Subsidiaries are in compliance.

                                       12
<PAGE>

          (o) Patents and Trademarks. The Borrowers and the Subsidiaries have,
     or have rights to use, all patents, patent applications, trademarks,
     trademark applications, service marks, trade names, copyrights, licenses
     and other similar rights necessary or material for use in connection with
     their respective businesses as described in the SEC Reports and which the
     failure to so have could have a Material Adverse Effect (collectively, the
     "Intellectual Property Rights"). Neither the Borrowers nor any Subsidiary
     have received a written notice that the Intellectual Property Rights used
     by the Borrowers or any Subsidiary violates or infringes upon the rights of
     any Person. To the knowledge of the Company, all such Intellectual Property
     Rights are enforceable and there is no existing infringement by another
     Person of any of the Intellectual Property Rights of others.

          (p) Insurance. The Borrowers and the Subsidiaries are insured by
     insurers of recognized financial responsibility against such losses and
     risks and in such amounts as are prudent and customary in the businesses in
     which the Borrowers and the Subsidiaries are engaged, including, but not
     limited to, directors and officers liability insurance coverage at least
     equal to the aggregate Subscription Amount. To the best knowledge of the
     Borrowers, such insurance contracts and policies are accurate and complete.
     Neither the Borrowers nor any Subsidiary has any reason to believe that it
     will not be able to renew its existing insurance coverage as and when such
     coverage expires or to obtain similar coverage from similar insurers as may
     be necessary to continue its business without a significant increase in
     cost.

          (q) Transactions With Affiliates and Employees. Except as set forth in
     the SEC Reports, none of the officers or directors of each Borrower and, to
     the knowledge of the Borrowers, none of the employees of either Borrower is
     presently a party to any transaction with the Company or any Subsidiary
     (other than for services as employees, officers and directors), including
     any contract, agreement or other arrangement providing for the furnishing
     of services to or by, providing for rental of real or personal property to
     or from, or otherwise requiring payments to or from any officer, director
     or such employee or, to the knowledge of the Borrowers, any entity in which
     any officer, director, or any such employee has a substantial interest or
     is an officer, director, trustee or partner, in each case in excess of
     $60,000 other than (i) for payment of salary or consulting fees for
     services rendered, (ii) reimbursement for expenses incurred on behalf of
     the Borrowers and (iii) for other employee benefits, including stock option
     agreements under any stock option plan of the Borrowers.

          (r) Sarbanes-Oxley; Internal Accounting Controls. The Company is in
     material compliance with all provisions of the Sarbanes-Oxley Act of 2002
     which are applicable to it as of the Closing Date. The Company and the
     Subsidiaries maintain a system of internal accounting controls sufficient
     to provide reasonable assurance that (i) transactions are executed in
     accordance with management's general or specific authorizations, (ii)
     transactions are recorded as necessary to permit preparation of financial
     statements in conformity with GAAP and to maintain asset accountability,
     (iii) access to assets is permitted only in accordance with management's
     general or specific authorization, and (iv) the recorded accountability for
     assets is compared with the

                                       13
<PAGE>

     existing assets at reasonable intervals and appropriate action is taken
     with respect to any differences. The Company has established disclosure
     controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
     15d-15(e)) for the Company and designed such disclosure controls and
     procedures to ensure that material information relating to the Company,
     including its Subsidiaries, is made known to the certifying officers by
     others within those entities, particularly during the period in which the
     Company's most recently filed periodic report under the Exchange Act, as
     the case may be, is being prepared. The Company's certifying officers have
     evaluated the effectiveness of the Company's controls and procedures as of
     the date prior to the filing date of the most recently filed periodic
     report under the Exchange Act (such date, the "Evaluation Date"). The
     Company presented in its most recently filed periodic report under the
     Exchange Act the conclusions of the certifying officers about the
     effectiveness of the disclosure controls and procedures based on their
     evaluations as of the Evaluation Date. Since the Evaluation Date, there
     have been no significant changes in the Company's internal controls (as
     such term is defined in Item 307(b) of Regulation S-K under the Exchange
     Act) or, to the knowledge of the Company, in other factors that could
     significantly affect the Company's internal controls.

          (s) Certain Fees. No brokerage or finder's fees or commissions are or
     will be payable by the Borrowers to any broker, financial advisor or
     consultant, finder, placement agent, investment banker, bank or other
     Person with respect to the transactions contemplated by the Transaction
     Documents. The Purchasers shall have no obligation with respect to any fees
     or with respect to any claims made by or on behalf of other Persons for
     fees of a type contemplated in this Section that may be due in connection
     with the transactions contemplated by the Transaction Documents.

          (t) Private Placement. Assuming the accuracy of the Purchasers
     representations and warranties set forth in Section 3.2, no registration
     under the Securities Act is required for the offer and sale of the
     Securities by the Borrowers to the Purchasers as contemplated hereby. The
     issuance and sale of the Securities hereunder does not contravene the rules
     and regulations of the Trading Market.

          (u) Investment Company. The Borrowers are not, and is not an Affiliate
     of, and immediately after receipt of payment for the Securities, will not
     be or be an Affiliate of, an "investment company" within the meaning of the
     Investment Company Act of 1940, as amended. The Borrowers shall conduct its
     business in a manner so that it will not become subject to the Investment
     Company Act.

          (v) Registration Rights. Other than each of the Purchasers, no Person
     has any right to cause the Company to effect the registration under the
     Securities Act of any securities of the Company.

          (w) Listing and Maintenance Requirements. The Company's Common Stock
     is registered pursuant to Section 12(g) of the Exchange Act, and the
     Company has taken no action designed to, or which to its knowledge is
     likely to have the effect of, terminating the registration of the Common
     Stock under the Exchange Act nor has the

                                       14
<PAGE>

     Company received any notification that the Commission is contemplating
     terminating such registration. The Company has not, in the 12 months
     preceding the date hereof, received notice from any Trading Market on which
     the Common Stock is or has been listed or quoted to the effect that the
     Company is not in compliance with the listing or maintenance requirements
     of such Trading Market. The Company is, and has no reason to believe that
     it will not in the foreseeable future continue to be, in compliance with
     all such listing and maintenance requirements.

          (x) Application of Takeover Protections. The Borrowers and their
     Boards of Directors have taken all necessary action, if any, in order to
     render inapplicable any control share acquisition, business combination,
     poison pill (including any distribution under a rights agreement) or other
     similar anti-takeover provision under the Company's Certificate of
     Incorporation (or similar charter documents) or the laws of its state of
     incorporation that is or could become applicable to the Purchasers as a
     result of the Purchasers and the Company fulfilling their obligations or
     exercising their rights under the Transaction Documents, including without
     limitation as a result of the Company's issuance of the Securities and the
     Purchasers' ownership of the Securities.

          (y) Disclosure. The Borrowers confirm that neither it nor any other
     Person acting on its behalf has provided any of the Purchasers or their
     agents or counsel with any information that constitutes or might constitute
     material, nonpublic information other than information contained in the
     Disclosure Schedules. The Borrowers understand and confirm that the
     Purchasers will rely on the foregoing representations and covenants in
     effecting transactions in securities of the Company. All disclosure
     provided to the Purchasers regarding the Borrowers, their businesses and
     the transactions contemplated hereby, including the Disclosure Schedules to
     this Agreement, furnished by or on behalf of the Borrowers with respect to
     the representations and warranties made herein are true and correct with
     respect to such representations and warranties and do not contain any
     untrue statement of a material fact or omit to state any material fact
     necessary in order to make the statements made therein, in light of the
     circumstances under which they were made, not misleading. The Borrowers
     acknowledge and agree that no Purchaser makes or has made any
     representations or warranties with respect to the transactions contemplated
     hereby other than those specifically set forth in Section 3.2 hereof.

          (z) No Integrated Offering. Assuming the accuracy of the Purchasers'
     representations and warranties set forth in Section 3.2, neither the
     Borrowers, nor any of their affiliates, nor any Person acting on its or
     their behalf has, directly or indirectly, made any offers or sales of any
     security or solicited any offers to buy any security, under circumstances
     that would cause this offering of the Securities to be integrated with
     prior offerings by the Company for purposes of the Securities Act or any
     applicable shareholder approval provisions, including, without limitation,
     under the rules and regulations of any Trading Market on which any of the
     securities of the Company are listed or designated.

          (aa) Solvency. Based on the financial condition of the Borrowers as of
     the Closing Date after giving effect to the receipt by the Borrowers of the
     proceeds from the

                                       15
<PAGE>

     sale of the Securities hereunder, (i) each Borrower's fair saleable value
     of its assets exceeds the amount that will be required to be paid on or in
     respect of its respective existing debts and other liabilities (including
     known contingent liabilities) as they mature; (ii) each Borrower's assets
     do not constitute unreasonably small capital to carry on its business for
     the current fiscal year as now conducted and as proposed to be conducted
     including its capital needs taking into account the particular capital
     requirements of the business conducted by the applicable Borrower, and
     projected capital requirements and capital availability thereof; and (iii)
     the current cash flow of each Borrower, together with the proceeds each
     Borrower would receive, were it to liquidate all of its assets, after
     taking into account all anticipated uses of the cash, would be sufficient
     to pay all amounts on or in respect of its debt when such amounts are
     required to be paid. The Borrowers do not intend to incur debts beyond its
     ability to pay such debts as they mature (taking into account the timing
     and amounts of cash to be payable on or in respect of its debt). The
     Company has no knowledge of any facts or circumstances which lead it to
     believe that it will file for reorganization or liquidation under the
     bankruptcy or reorganization laws of any jurisdiction within one year from
     the Closing Date. The SEC Reports set forth as of the dates thereof all
     outstanding secured and unsecured Indebtedness of Borrowers, as applicable,
     or any Subsidiary, or for which the Company or any Subsidiary has
     commitments. For the purposes of this Agreement, "Indebtedness" shall mean
     (a) any liabilities for borrowed money or amounts owed in excess of $50,000
     (other than trade accounts payable incurred in the ordinary course of
     business), (b) all guaranties, endorsements and other contingent
     obligations in respect of Indebtedness of others, whether or not the same
     are or should be reflected in each Borrower's balance sheet (or the notes
     thereto), except guaranties by endorsement of negotiable instruments for
     deposit or collection or similar transactions in the ordinary course of
     business; and (c) the present value of any lease payments in excess of
     $50,000 due under leases required to be capitalized in accordance with
     GAAP. Neither the Borrowers nor any Subsidiary is in default with respect
     to any Indebtedness.

          (bb) Form SB-2 Eligibility. The Company is eligible to register the
     resale of the Underlying Shares for resale by the Purchaser on Form SB-2
     promulgated under the Securities Act.

          (cc) Tax Status. Except for matters that would not, individually or in
     the aggregate, have or reasonably be expected to result in a Material
     Adverse Effect, the Borrowers and each Subsidiary have filed all necessary
     federal, state and foreign income and franchise tax returns and has paid or
     accrued all taxes shown as due thereon, and the Borrowers have no knowledge
     of a tax deficiency which has been asserted or threatened against the
     Borrowers or any Subsidiary.

          (dd) No General Solicitation. Neither the Borrowers nor any person
     acting on behalf of the Company has offered or sold any of the Securities
     by any form of general solicitation or general advertising. The Borrowers
     have offered the Securities for sale only to the Purchasers and certain
     other "accredited investors" within the meaning of Rule 501 under the
     Securities Act.

                                       16
<PAGE>

          (ee) Foreign Corrupt Practices. Neither the Company, nor to the
     knowledge of the Company, any agent or other person acting on behalf of the
     Company, has (i) directly or indirectly, used any funds for unlawful
     contributions, gifts, entertainment or other unlawful expenses related to
     foreign or domestic political activity, (ii) made any unlawful payment to
     foreign or domestic government officials or employees or to any foreign or
     domestic political parties or campaigns from corporate funds, (iii) failed
     to disclose fully any contribution made by the Company (or made by any
     person acting on its behalf of which the Company is aware) which is in
     violation of law, or (iv) violated in any material respect any provision of
     the Foreign Corrupt Practices Act of 1977, as amended.

          (ff) Accountants. Each Borrower's accountants are set forth on
     Schedule 3.1(ff) of the Disclosure Schedule. To the knowledge of the
     Company, such accountants, who the Company expects will express their
     opinion with respect to the financial statements to be included in the
     Company's Annual Report on Form 10-KSB for the year ended December 31, 2005
     are a registered public accounting firm as required by the Securities Act.

          (gg) Seniority. As of the Closing Date, no indebtedness or other
     equity of the Borrowers is senior to the Debentures in right of payment,
     whether with respect to interest or upon liquidation or dissolution, or
     otherwise, other than indebtedness secured by purchase money security
     interests (which is senior only as to underlying assets covered thereby)
     and capital lease obligations (which is senior only as to the property
     covered thereby).

          (hh) No Disagreements with Accountants and Lawyers. There are no
     disagreements of any kind presently existing, or reasonably anticipated by
     the Borrowers to arise, between the accountants and lawyers formerly or
     presently employed by the Borrowers and the Borrowers are current with
     respect to any fees owed to its accountants and lawyers.

          (ii) Acknowledgment Regarding Purchasers' Purchase of Securities. The
     Company acknowledges and agrees that each of the Purchasers is acting
     solely in the capacity of an arm's length purchaser with respect to the
     Transaction Documents and the transactions contemplated hereby. The Company
     further acknowledges that no Purchaser is acting as a financial advisor or
     fiduciary of the Company (or in any similar capacity) with respect to this
     Agreement and the transactions contemplated hereby and any advice given by
     any Purchaser or any of their respective representatives or agents in
     connection with this Agreement and the transactions contemplated hereby is
     merely incidental to the Purchasers' purchase of the Securities. The
     Company further represents to each Purchaser that the Company's decision to
     enter into this Agreement has been based solely on the independent
     evaluation of the transactions contemplated hereby by the Company and its
     representatives.

          (jj) Acknowledgement Regarding Purchasers' Trading Activity. Anything
     in this Agreement or elsewhere herein to the contrary notwithstanding
     (except for Section 4.16 hereof), it is understood and agreed by the
     Company (i) that none of the Purchasers

                                       17
<PAGE>

     have been asked to agree, nor has any Purchaser agreed, to desist from
     purchasing or selling, long and/or short, securities of the Company, or
     "derivative" securities based on securities issued by the Company or to
     hold the Securities for any specified term; (ii) that past or future open
     market or other transactions by any Purchaser, including Short Sales, and
     specifically including, without limitation, Short Sales or "derivative"
     transactions, before or after the closing of this or future private
     placement transactions, may negatively impact the market price of the
     Company's publicly-traded securities; (iii) that any Purchaser, and counter
     parties in "derivative" transactions to which any such Purchaser is a
     party, directly or indirectly, presently may have a "short" position in the
     Common Stock, and (iv) that each Purchaser shall not be deemed to have any
     affiliation with or control over any arm's length counter-party in any
     "derivative" transaction. The Company further understands and acknowledges
     that (a) one or more Purchasers may engage in hedging activities at various
     times during the period that the Securities are outstanding, including,
     without limitation, during the periods that the value of the Underlying
     Shares deliverable with respect to Securities are being determined and (b)
     such hedging activities (if any) could reduce the value of the existing
     stockholders' equity interests in the Company at and after the time that
     the hedging activities are being conducted. The Company acknowledges that
     such aforementioned hedging activities do not constitute a breach of any of
     the Transaction Documents.

          (kk) Manipulation of Price. The Company has not, and to its knowledge
     no one acting on its behalf has, (i) taken, directly or indirectly, any
     action designed to cause or to result in the stabilization or manipulation
     of the price of any security of the Company to facilitate the sale or
     resale of any of the Securities, (ii) sold, bid for, purchased, or, paid
     any compensation for soliciting purchases of, any of the Securities (other
     than for the placement agent's placement of the Securities), or (iii) paid
     or agreed to pay to any person any compensation for soliciting another to
     purchase any other securities of the Company.

     3.2 Representations and Warranties of the Purchasers. Each Purchaser
hereby, for itself and for no other Purchaser, represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows:

          (a) Organization; Authority. Such Purchaser is an entity duly
     organized, validly existing and in good standing under the laws of the
     jurisdiction of its organization with full right, corporate or partnership
     power and authority to enter into and to consummate the transactions
     contemplated by the Transaction Documents and otherwise to carry out its
     obligations hereunder and thereunder. The execution, delivery and
     performance by such Purchaser of the transactions contemplated by this
     Agreement have been duly authorized by all necessary corporate or similar
     action on the part of such Purchaser. Each Transaction Document to which it
     is a party has been duly executed by such Purchaser, and when delivered by
     such Purchaser in accordance with the terms hereof, will constitute the
     valid and legally binding obligation of such Purchaser, enforceable against
     it in accordance with its terms, except (i) as limited by general equitable
     principles and applicable bankruptcy, insolvency, reorganization,
     moratorium and other laws of general application affecting enforcement of
     creditors' rights generally,

                                       18
<PAGE>

     (ii) as limited by laws relating to the availability of specific
     performance, injunctive relief or other equitable remedies and (iii)
     insofar as indemnification and contribution provisions may be limited by
     applicable law.

          (b) Own Account. Such Purchaser understands that the Securities are
     "restricted securities" and have not been registered under the Securities
     Act or any applicable state securities law and is acquiring the Securities
     as principal for its own account and not with a view to or for distributing
     or reselling such Securities or any part thereof in violation of the
     Securities Act or any applicable state securities law, has no present
     intention of distributing any of such Securities in violation of the
     Securities Act or any applicable state securities law and has no
     arrangement or understanding with any other persons regarding the
     distribution of such Securities (this representation and warranty not
     limiting such Purchaser's right to sell the Securities pursuant to the
     Registration Statement or otherwise in compliance with applicable federal
     and state securities laws) in violation of the Securities Act or any
     applicable state securities law. Such Purchaser is acquiring the Securities
     hereunder in the ordinary course of its business. Such Purchaser does not
     have any agreement or understanding, directly or indirectly, with any
     Person to distribute any of the Securities.

          (c) Purchaser Status. At the time such Purchaser was offered the
     Securities, it was, and at the date hereof it is, and on each date on which
     it exercises any Warrants or converts any Debentures it will be either: (i)
     an "accredited investor" as defined in Rule 501(a)(1), (a)(2), (a)(3),
     (a)(7) or (a)(8) under the Securities Act or (ii) a "qualified
     institutional buyer" as defined in Rule 144A(a) under the Securities Act.
     Such Purchaser is not required to be registered as a broker-dealer under
     Section 15 of the Exchange Act.

          (d) Experience of Such Purchaser. Such Purchaser, either alone or
     together with its representatives, has such knowledge, sophistication and
     experience in business and financial matters so as to be capable of
     evaluating the merits and risks of the prospective investment in the
     Securities, and has so evaluated the merits and risks of such investment.
     Such Purchaser is able to bear the economic risk of an investment in the
     Securities and, at the present time, is able to afford a complete loss of
     such investment.

          (e) General Solicitation. Such Purchaser is not purchasing the
     Securities as a result of any advertisement, article, notice or other
     communication regarding the Securities published in any newspaper, magazine
     or similar media or broadcast over television or radio or presented at any
     seminar or any other general solicitation or general advertisement.

          (f) Short Sales and Confidentiality Prior To The Date Hereof. Other
     than the transaction contemplated hereunder, such Purchaser has not
     directly or indirectly, nor has any Person acting on behalf of or pursuant
     to any understanding with such Purchaser, executed any disposition,
     including Short Sales (but not including the location and/or reservation of
     borrowable shares of Common Stock), in the securities of the Company during
     the period commencing from the time that such Purchaser first received a
     term sheet from the Company or any other Person setting forth the material
     terms of the

                                       19
<PAGE>

     transactions contemplated hereunder until the date hereof ("Discussion
     Time"). Notwithstanding the foregoing, in the case of a Purchaser that is a
     multi-managed investment vehicle whereby separate portfolio managers manage
     separate portions of such Purchaser's assets and the portfolio managers
     have no direct knowledge of the investment decisions made by the portfolio
     managers managing other portions of such Purchaser's assets, the
     representation set forth above shall only apply with respect to the portion
     of assets managed by the portfolio manager that made the investment
     decision to purchase the Securities covered by this Agreement. Other than
     to other Persons party to this Agreement, such Purchaser has maintained the
     confidentiality of all disclosures made to it in connection with this
     transaction (including the existence and terms of this transaction).

          The Borrowers acknowledge and agree that each Purchaser does not make
     or has not made any representations or warranties with respect to the
     transactions contemplated hereby other than those specifically set forth in
     this Section 3.2.

                                   ARTICLE IV.
                         OTHER AGREEMENTS OF THE PARTIES

     4.1 Transfer Restrictions.

          (a) The Securities may only be disposed of in compliance with state
     and federal securities laws. In connection with any transfer of Securities
     other than pursuant to an effective registration statement or Rule 144, to
     the Company or to an affiliate of a Purchaser or in connection with a
     pledge as contemplated in Section 4.1(b), the Company may require the
     transferor thereof to provide to the Company an opinion of counsel selected
     by the transferor and reasonably acceptable to the Company, the form and
     substance of which opinion shall be reasonably satisfactory to the Company,
     to the effect that such transfer does not require registration of such
     transferred Securities under the Securities Act. As a condition of
     transfer, any such transferee shall agree in writing to be bound by the
     terms of this Agreement and shall have the rights of a Purchaser under this
     Agreement and the Registration Rights Agreement.

          (b) The Purchasers agree to the imprinting, so long as is required by
     this Section 4.1(b), of a legend on any of the Securities in the following
     form:

     [NEITHER] THESE SECURITIES [NOR THE SECURITIES INTO WHICH THESE SECURITIES
     ARE [EXERCISABLE] [CONVERTIBLE]] HAVE BEEN REGISTERED WITH THE SECURITIES
     AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
     RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF
     1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE
     OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
     UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN
     A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
     SECURITIES ACT AND IN

                                       20
<PAGE>

     ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
     OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH
     SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE
     SECURITIES ISSUABLE UPON [EXERCISE] [CONVERSION] OF THESE SECURITIES MAY BE
     PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED
     BY SUCH SECURITIES.

          The Borrowers acknowledge and agree that a Purchaser may from time to
     time pledge pursuant to a bona fide margin agreement with a registered
     broker-dealer or grant a security interest in some or all of the Securities
     to a financial institution that is an "accredited investor" as defined in
     Rule 501(a) under the Securities Act and who agrees to be bound by the
     provisions of this Agreement and the Registration Rights Agreement and, if
     required under the terms of such arrangement, such Purchaser may transfer
     pledged or secured Securities to the pledgees or secured parties. Such a
     pledge or transfer would not be subject to approval of the Borrowers and no
     legal opinion of legal counsel of the pledgee, secured party or pledgor
     shall be required in connection therewith. Further, no notice shall be
     required of such pledge. At the appropriate Purchaser's expense, the
     Borrowers will execute and deliver such reasonable documentation as a
     pledgee or secured party of Securities may reasonably request in connection
     with a pledge or transfer of the Securities, including, if the Securities
     are subject to registration pursuant to the Registration Rights Agreement,
     the preparation and filing of any required prospectus supplement under Rule
     424(b)(3) under the Securities Act or other applicable provision of the
     Securities Act to appropriately amend the list of Selling Stockholders
     thereunder.

          (c) Certificates evidencing the Underlying Shares shall not contain
     any legend (including the legend set forth in Section 4.1(b) hereof): (i)
     while a registration statement (including the Registration Statement)
     covering the resale of such security is effective under the Securities Act,
     or (ii) following any sale of such Underlying Shares pursuant to Rule 144,
     or (iii) if such Underlying Shares are eligible for sale under Rule 144(k),
     or (iv) if such legend is not required under applicable requirements of the
     Securities Act (including judicial interpretations and pronouncements
     issued by the staff of the Commission). The Company shall cause its counsel
     to issue a legal opinion to the Company's transfer agent promptly after the
     Effective Date if required by the Company's transfer agent to effect the
     removal of the legend hereunder. If all or any portion of a Debenture or
     Warrant is converted or exercised (as applicable) at a time when there is
     an effective registration statement to cover the resale of the Underlying
     Shares, or if such Underlying Shares may be sold under Rule 144(k) or if
     such legend is not otherwise required under applicable requirements of the
     Securities Act (including judicial interpretations thereof) then such
     Underlying Shares shall be issued free of all legends. The Company agrees
     that following the Effective Date or at such time as such legend is no
     longer required under this Section 4.1(c), it will, no later than three
     Trading Days following the delivery by a Purchaser to the Company or the
     Company's transfer agent of a certificate representing Underlying Shares,
     as applicable, issued with a restrictive legend (such third Trading Day,
     the "Legend Removal Date"), deliver or cause to be

                                       21
<PAGE>

     delivered to such Purchaser a certificate representing such shares that is
     free from all restrictive and other legends. The Company may not make any
     notation on its records or give instructions to any transfer agent of the
     Company that enlarge the restrictions on transfer set forth in this
     Section. Certificates for Securities subject to legend removal hereunder
     shall be transmitted by the transfer agent of the Company to the Purchasers
     by crediting the account of the Purchaser's prime broker with the
     Depository Trust Company System.

          (d) In addition to such Purchaser's other available remedies, the
     Borrowers shall pay, jointly and severally, to a Purchaser, in cash, as
     partial liquidated damages and not as a penalty, for each $1,000 of
     Underlying Shares (based on the VWAP of the Common Stock on the date such
     Securities are submitted to the Company's transfer agent) delivered for
     removal of the restrictive legend and subject to Section 4.1(c), $10 per
     Trading Day (increasing to $20 per Trading Day 5 Trading Days after such
     damages have begun to accrue) for each Trading Day after the second Trading
     Day after the Legend Removal Date until such certificate is delivered
     without a legend. Nothing herein shall limit such Purchaser's right to
     pursue actual damages for the Company's failure to deliver certificates
     representing any Securities as required by the Transaction Documents, and
     such Purchaser shall have the right to pursue all remedies available to it
     at law or in equity including, without limitation, a decree of specific
     performance and/or injunctive relief.

          (e) Each Purchaser, severally and not jointly with the other
     Purchasers, agrees that the removal of the restrictive legend from
     certificates representing Securities as set forth in this Section 4.1 is
     predicated upon the Company's reliance that the Purchaser will sell any
     Securities pursuant to either the registration requirements of the
     Securities Act, including any applicable prospectus delivery requirements,
     or an exemption therefrom.

     4.2 Acknowledgment of Dilution. The Company acknowledges that the issuance
of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The
Company further acknowledges that its obligations under the Transaction
Documents, including without limitation its obligation to issue the Underlying
Shares pursuant to the Transaction Documents, are unconditional and absolute and
not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have
against any Purchaser and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.

     4.3 Furnishing of Information. As long as any Purchaser owns Securities,
the Company covenants to timely file (or obtain extensions in respect thereof
and file within the applicable grace period) all reports required to be filed by
the Company after the date hereof pursuant to the Exchange Act. As long as any
Purchaser owns Securities, if the Company is not required to file reports
pursuant to the Exchange Act, it will prepare and furnish to the Purchasers and
make publicly available in accordance with Rule 144(c) such information as is
required for the Purchasers to sell the Securities under Rule 144. The Company
further covenants that it will take such further action as any holder of
Securities may reasonably request,

                                       22
<PAGE>

all to the extent required from time to time to enable such Person to sell such
Securities without registration under the Securities Act within the limitation
of the exemptions provided by Rule 144.

     4.4 Integration. The Company shall not sell, offer for sale or solicit
offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale
of the Securities in a manner that would require the registration under the
Securities Act of the sale of the Securities to the Purchasers or that would be
integrated with the offer or sale of the Securities for purposes of the rules
and regulations of any Trading Market.

     4.5 Conversion and Exercise Procedures. The form of Notice of Exercise
included in the Warrants and the form of Notice of Conversion included in the
Debentures set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants or convert the Debentures. No additional legal
opinion or other information or instructions shall be required of the Purchasers
to exercise their Warrants or convert their Debentures. The Company shall honor
exercises of the Warrants and conversions of the Debentures and shall deliver
Underlying Shares in accordance with the terms, conditions and time periods set
forth in the Transaction Documents.

     4.6 Securities Laws Disclosure; Publicity. The Company shall, by 8:30 a.m.
Eastern time on the second Trading Day following the date hereof, issue a
Current Report on Form 8-K, reasonably acceptable to each Purchaser disclosing
the material terms of the transactions contemplated hereby, and shall attach the
Transaction Documents thereto. The Borrowers and each Purchaser shall consult
with each other in issuing any other press releases with respect to the
transactions contemplated hereby, and neither the Borrowers nor any Purchaser
shall issue any such press release or otherwise make any such public statement
without the prior consent of the Borrowers, with respect to any press release of
any Purchaser, or without the prior consent of each Purchaser, with respect to
any press release of the Borrowers, which consent shall not unreasonably be
withheld, except if such disclosure is required by law, in which case the
disclosing party shall promptly provide the other party with prior notice of
such public statement or communication. Notwithstanding the foregoing, the
Company shall not publicly disclose the name of any Purchaser, or include the
name of any Purchaser in any filing with the Commission or any regulatory agency
or Trading Market, without the prior written consent of such Purchaser, except
(i) as required by federal securities law in connection with the registration
statement contemplated by the Registration Rights Agreement and (ii) to the
extent such disclosure is required by law or Trading Market regulations, in
which case the Company shall provide the Purchasers with prior notice of such
disclosure permitted under subclause (i) or (ii).

     4.7 Shareholder Rights Plan. No claim will be made or enforced by the
Company or, to the knowledge of the Company, any other Person that any Purchaser
is an "Acquiring Person" under any shareholder rights plan or similar plan or
arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by
virtue of receiving Securities under the Transaction Documents or under any
other agreement between the Company and the Purchasers. The Company shall
conduct its business in a manner so that it will not become subject to the
Investment Company Act.

                                       23
<PAGE>

     4.8 Non-Public Information. The Borrowers covenant and agree that neither
it nor any other Person acting on its behalf will provide any Purchaser or its
agents or counsel with any information that the Borrowers believe constitutes
material non-public information, unless prior thereto such Purchaser shall have
executed a written agreement regarding the confidentiality and use of such
information. The Borrowers understand and confirm that each Purchaser shall be
relying on the foregoing representations in effecting transactions in securities
of the Company.

     4.9 Use of Proceeds. The Borrowers shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes including, but not
limited to, the purchase of distressed real property and distressed consumer
receivable portfolios and not for the satisfaction of any portion of either
Borrower's debt (other than payment of trade payables in the ordinary course of
the Borrowers' business and prior practices), to redeem any Common Stock or
Common Stock Equivalents or to settle any outstanding litigation.

     4.10 Reimbursement. If any Purchaser becomes involved in any capacity in
any Proceeding by or against any Person who is a stockholder of the Borrowers
(except as a result of sales, pledges, margin sales and similar transactions by
such Purchaser to or with any current stockholder or unless such Proceeding is
based upon a breach of such Purchaser's representations, warranties or covenants
under the Transaction Documents or any agreements or understandings such
Purchaser may have with any such stockholder or any violations by the Purchaser
of state or federal securities laws or any conduct by such Purchaser which
constitutes fraud or willful misconduct), solely as a result of such Purchaser's
acquisition of the Securities under this Agreement, the Borrowers will jointly
and severally reimburse such Purchaser for its reasonable legal and other
expenses (including the cost of any investigation preparation and travel in
connection therewith) incurred in connection therewith, as such expenses are
incurred. The reimbursement obligations of the Borrowers under this paragraph
shall be in addition to any liability which the Borrowers may otherwise have,
shall extend upon the same terms and conditions to any Affiliates of the
Purchasers who are actually named in such action, proceeding or investigation,
and partners, directors, agents, employees and controlling persons (if any), as
the case may be, of the Purchasers and any such Affiliate, and shall be binding
upon and inure to the benefit of any successors, assigns, heirs and personal
representatives of the Borrowers, the Purchasers and any such Affiliate and any
such Person. The Borrowers also agree that neither the Purchasers nor any such
Affiliates, partners, directors, agents, employees or controlling persons shall
have any liability to the Borrowers or any Person asserting claims on behalf of
or in right of the Borrowers solely as a result of acquiring the Securities
under this Agreement.

     4.11 Indemnification of Purchasers. Subject to the provisions of this
Section 4.11, the Borrowers will jointly and severally indemnify and hold the
Purchasers and their directors, officers, shareholders, members, partners,
employees and agents (each, a "Purchaser Party") harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and
expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys' fees and costs of investigation that any such Purchaser
Party may suffer or incur as a result of or relating to (a) any breach of any of
the representations, warranties, covenants or agreements made by the Borrowers
in this Agreement or in the other Transaction Documents or (b) any action
instituted against a Purchaser, or any of them or their respective Affiliates,
by any stockholder of the Borrowers who is not an Affiliate of such Purchaser,
with respect to any of the

                                       24
<PAGE>

transactions contemplated by the Transaction Documents (unless such action is
based upon a breach of such Purchaser's representations, warranties or covenants
under the Transaction Documents or any agreements or understandings such
Purchaser may have with any such stockholder or any violations by the Purchaser
of state or federal securities laws or any conduct by such Purchaser which
constitutes fraud, gross negligence, willful misconduct or malfeasance). If any
action shall be brought against any Purchaser Party in respect of which
indemnity may be sought pursuant to this Agreement, such Purchaser Party shall
promptly notify the Borrowers in writing, and the Borrowers shall have the right
to assume the defense thereof with counsel of its own choosing. Any Purchaser
Party shall have the right to employ separate counsel in any such action and
participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Purchaser Party except to the extent that (i)
the employment thereof has been specifically authorized by the Borrowers in
writing, (ii) the Borrowers have failed after a reasonable period of time to
assume such defense and to employ counsel or (iii) in such action there is, in
the reasonable opinion of such separate counsel, a material conflict on any
material issue between the position of either Borrower and the position of such
Purchaser Party. The Borrowers will not be liable to any Purchaser Party under
this Agreement (i) for any settlement by a Purchaser Party effected without each
Borrower's prior written consent, which shall not be unreasonably withheld or
delayed; or (ii) to the extent, but only to the extent that a loss, claim,
damage or liability is attributable to any Purchaser Party's breach of any of
the representations, warranties, covenants or agreements made by the Purchasers
in this Agreement or in the other Transaction Documents.

     4.12 Reservation and Listing of Securities.

          (a) The Company shall maintain a reserve from its duly authorized
     shares of Common Stock for issuance pursuant to the Transaction Documents
     in such amount as may be required to fulfill its obligations in full under
     the Transaction Documents.

          (b) If, on any date, the number of authorized but unissued (and
     otherwise unreserved) shares of Common Stock is less than the Required
     Minimum on such date, then the Board of Directors of the Company shall use
     commercially reasonable efforts to amend the Company's certificate or
     articles of incorporation to increase the number of authorized but unissued
     shares of Common Stock to at least the Required Minimum at such time, as
     soon as possible and in any event not later than the 75th day after such
     date.

          (c) The Company shall, if applicable: (i) in the time and manner
     required by the Trading Market, prepare and file with such Trading Market
     an additional shares listing application covering a number of shares of
     Common Stock at least equal to the Required Minimum on the date of such
     application, (ii) take all steps necessary to cause such shares of Common
     Stock to be approved for listing on the Trading Market as soon as possible
     thereafter, (iii) provide to the Purchasers evidence of such listing, and
     (iv) maintain the listing of such Common Stock on any date at least equal
     to the Required Minimum on such date on such Trading Market or another
     Trading Market.

     4.13 Participation in Future Financing.

                                       25
<PAGE>

          (a) From the date hereof until the date that is the 12 month
     anniversary of the Effective Date, upon any financing by the Company or any
     of its Subsidiaries of Common Stock, Common Stock Equivalents or
     Indebtedness of a Borrower (a "Subsequent Financing"), each Purchaser shall
     have the right to participate in up to an amount of the Subsequent
     Financing equal to 100% of the Subsequent Financing (the "Participation
     Maximum").

          (b) At least 5 Trading Days prior to the closing of the Subsequent
     Financing, the Borrowers shall deliver to each Purchaser a written notice
     of its intention to effect a Subsequent Financing ("Pre-Notice"), which
     Pre-Notice shall ask such Purchaser if it wants to review the details of
     such financing (such additional notice, a "Subsequent Financing Notice").
     Upon the request of a Purchaser, and only upon a request by such Purchaser,
     for a Subsequent Financing Notice, the Borrowers shall promptly, but no
     later than 1 Trading Day after such request, deliver a Subsequent Financing
     Notice to such Purchaser. The Subsequent Financing Notice shall describe in
     reasonable detail the proposed terms of such Subsequent Financing, the
     amount of proceeds intended to be raised thereunder, the Person with whom
     such Subsequent Financing is proposed to be effected, and attached to which
     shall be a term sheet or similar document relating thereto.

          (c) Any Purchaser desiring to participate in such Subsequent Financing
     must provide written notice to the Borrowers by not later than 5:30 p.m.
     (New York City time) on the 5th Trading Day after all of the Purchasers
     have received the Pre-Notice that the Purchaser is willing to participate
     in the Subsequent Financing, the amount of the Purchaser's participation,
     and that the Purchaser has such funds ready, willing, and available for
     investment on the terms set forth in the Subsequent Financing Notice. If
     the Borrowers receives no notice from a Purchaser as of such 5th Trading
     Day, such Purchaser shall be deemed to have notified the Borrowers that it
     does not elect to participate.

          (d) If by 5:30 p.m. (New York City time) on the 5th Trading Day after
     all of the Purchasers have received the Pre-Notice, notifications by the
     Purchasers of their willingness to participate in the Subsequent Financing
     (or to cause their designees to participate) is, in the aggregate, less
     than the total amount of the Subsequent Financing, then the Borrowers may
     effect the remaining portion of such Subsequent Financing on the terms and
     to the Persons set forth in the Subsequent Financing Notice.

          (e) If by 5:30 p.m. (New York City time) on the 5th Trading Day after
     all of the Purchasers have received the Pre-Notice, the Borrowers receives
     responses to a Subsequent Financing Notice from Purchasers seeking to
     purchase more than the aggregate amount of the Participation Maximum, each
     such Purchaser shall have the right to purchase the greater of (a) their
     Pro Rata Portion (as defined below) of the Participation Maximum and (b)
     the difference between the Participation Maximum and the aggregate amount
     of participation by all other Purchasers. "Pro Rata Portion" is the ratio
     of (x) the Subscription Amount of Securities purchased on the Closing Date
     by a Purchaser participating under this Section 4.13 and (y) the sum of the
     aggregate

                                       26
<PAGE>

     Subscription Amounts of Securities purchased on the Closing Date by all
     Purchasers participating under this Section 4.13.

          (f) The Borrowers must provide the Purchasers with a second Subsequent
     Financing Notice, and the Purchasers will again have the right of
     participation set forth above in this Section 4.13, if the Subsequent
     Financing subject to the initial Subsequent Financing Notice is not
     consummated for any reason on the terms set forth in such Subsequent
     Financing Notice within 60 Trading Days after the date of the initial
     Subsequent Financing Notice.

          (g) Notwithstanding the foregoing, this Section 4.13 shall not apply
     in respect of (i) an Exempt Issuance and (ii) a Secondary Offering.

     4.14 Subsequent Equity Sales.

          (a) From the date hereof until 90 days after the Effective Date,
     neither the Borrowers nor any Subsidiary shall issue shares of Common Stock
     or Common Stock Equivalents; provided, however, the 90 day period set forth
     in this Section 4.14 shall be extended for the number of Trading Days
     during such period in which (i) trading in the Common Stock is suspended by
     any Trading Market, or (ii) following the Effective Date, the Registration
     Statement is not effective or the prospectus included in the Registration
     Statement may not be used by the Purchasers for the resale of the
     Underlying Shares.

          (b) From the date hereof until such time as no Purchaser holds any of
     the Securities, the Company shall be prohibited from effecting or entering
     into an agreement to effect any Subsequent Financing involving a "Variable
     Rate Transaction". The term "Variable Rate Transaction" shall mean a
     transaction in which the Company issues or sells (i) any debt or equity
     securities that are convertible into, exchangeable or exercisable for, or
     include the right to receive additional shares of Common Stock either (A)
     at a conversion, exercise or exchange rate or other price that is based
     upon and/or varies with the trading prices of or quotations for the shares
     of Common Stock at any time after the initial issuance of such debt or
     equity securities, or (B) with a conversion, exercise or exchange price
     that is subject to being reset at some future date after the initial
     issuance of such debt or equity security (but not including customary full
     ratchet or weighted average anti-dilution provisions), or upon the
     occurrence of specified or contingent events directly or indirectly related
     to the business of the Company or the market for the Common Stock or (ii)
     enters into any agreement, including, but not limited to, an equity line of
     credit, whereby the Company may sell securities at a future determined
     price.

          (c) Notwithstanding the foregoing, this Section 4.14 shall not apply
     in respect of an Exempt Issuance or a Secondary Offering, except that no
     Variable Rate Transaction shall be an Exempt Issuance.

     4.15 Equal Treatment of Purchasers. No consideration shall be offered or
paid to any person to amend or consent to a waiver or modification of any
provision of any of the

                                       27
<PAGE>

Transaction Documents unless the same consideration is also offered to all of
the parties to the Transaction Documents. Further, the Borrowers shall not make
any payment of principal or interest on the Debentures in amounts which are
disproportionate to the respective principal amounts outstanding on the
Debentures at any applicable time. For clarification purposes, this provision
constitutes a separate right granted to each Purchaser by the Borrowers and
negotiated separately by each Purchaser, and is intended for the Borrowers to
treat the Purchasers as a class and shall not in any way be construed as the
Purchasers acting in concert or as a group with respect to the purchase,
disposition or voting of Securities or otherwise.

     4.16 Short Sales and Confidentiality After The Date Hereof. Each Purchaser
severally and not jointly with the other Purchasers covenants that neither it
nor any affiliates acting on its behalf or pursuant to any understanding with it
will execute any Short Sales during the period after the Discussion Time and
ending at the time that the transactions contemplated by this Agreement are
first publicly announced as described in Section 4.6. Each Purchaser, severally
and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the
Company as described in Section 4.6, such Purchaser will maintain, the
confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Each
Purchaser understands and acknowledges, severally and not jointly with any other
Purchaser, that the Commission currently takes the position that coverage of
short sales of shares of the Common Stock "against the box" prior to the
Effective Date of the Registration Statement with the Securities is a violation
of Section 5 of the Securities Act, as set forth in Item 65, Section 5 under
Section A, of the Manual of Publicly Available Telephone Interpretations, dated
July 1997, compiled by the Office of Chief Counsel, Division of Corporation
Finance. Notwithstanding the foregoing, no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in Short Sales in the
securities of the Company after the time that the transactions contemplated by
this Agreement are first publicly announced as described in Section 4.6.
Notwithstanding the foregoing, in the case of a Purchaser that is a
multi-managed investment vehicle whereby separate portfolio managers manage
separate portions of such Purchaser's assets and the portfolio managers have no
direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser's assets, the covenant set forth above
shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by
this Agreement.

                                   ARTICLE V.
                                  MISCELLANEOUS

     5.1 Termination. This Agreement may be terminated by any Purchaser, as to
such Purchaser's obligations hereunder only and without any effect whatsoever on
the obligations between the Borrowers and the other Purchasers, by written
notice to the other parties, if the Closing has not been consummated on or
before October 31, 2005; provided, however, that no such termination will affect
the right of any party to sue for any breach by the other party (or parties).

     5.2 Fees and Expenses. At the Closing, the Borrowers have agreed to jointly
and severally reimburse DKR SoundShore Oasis Holding Fund Ltd. ("DKR")
non-accountable sum

                                       28
<PAGE>

of $30,000, for its actual, reasonable, out-of-pocket legal fees and expenses.
Accordingly, in lieu of the foregoing payments, the aggregate amount that DKR is
to pay for the Securities at the Closing shall be reduced by $30,000 in lieu
thereof. The Borrowers shall deliver, prior to the Closing, a completed and
executed copy of the Closing Statement, attached hereto as Annex A. Except as
expressly set forth in the Transaction Documents to the contrary, each party
shall pay the fees and expenses of its advisers, counsel, accountants and other
experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement.
The Borrowers shall pay all transfer agent fees, stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities.

     5.3 Entire Agreement. The Transaction Documents, together with the exhibits
and schedules thereto, contain the entire understanding of the parties with
respect to the subject matter hereof and supersede all prior agreements and
understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules.

     5.4 Notices. Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be
deemed given and effective on the earliest of (a) the date of transmission, if
such notice or communication is delivered via facsimile at the facsimile number
set forth on the signature pages attached hereto prior to 5:30 p.m. (New York
City time) on a Trading Day, (b) the next Trading Day after the date of
transmission, if such notice or communication is delivered via facsimile at the
facsimile number set forth on the signature pages attached hereto on a day that
is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading
Day, (c) the 2nd Trading Day following the date of mailing, if sent by U.S.
nationally recognized overnight courier service, or (d) upon actual receipt by
the party to whom such notice is required to be given. The address for such
notices and communications shall be as set forth on the signature pages attached
hereto.

     5.5 Amendments; Waivers. No provision of this Agreement may be waived or
amended except in a written instrument signed, in the case of an amendment, by
the Borrowers and each Purchaser or, in the case of a waiver, by the party
against whom enforcement of any such waiver is sought. No waiver of any default
with respect to any provision, condition or requirement of this Agreement shall
be deemed to be a continuing waiver in the future or a waiver of any subsequent
default or a waiver of any other provision, condition or requirement hereof, nor
shall any delay or omission of either party to exercise any right hereunder in
any manner impair the exercise of any such right.

     5.6 Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof. The language used in this Agreement will be deemed
to be the language chosen by the parties to express their mutual intent, and no
rules of strict construction will be applied against any party.

     5.7 Successors and Assigns. This Agreement shall be binding upon and inure
to the benefit of the parties and their successors and permitted assigns. The
Borrowers may not assign this Agreement or any rights or obligations hereunder
without the prior written consent of each Purchaser. Any Purchaser may assign
any or all of its rights under this Agreement to any Person

                                       29
<PAGE>

to whom such Purchaser assigns or transfers any Securities, provided such
transferee agrees in writing to be bound, with respect to the transferred
Securities, by the provisions hereof that apply to the "Purchasers".

     5.8 No Third-Party Beneficiaries. This Agreement is intended for the
benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person, except as otherwise set forth in Section 4.11.

     5.9 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of
New York, without regard to the principles of conflicts of law thereof. Each
party agrees that all legal proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement and
any other Transaction Documents (whether brought against a party hereto or its
respective affiliates, directors, officers, shareholders, employees or agents)
shall be commenced exclusively in the state and federal courts sitting in the
City of New York. Each party hereby irrevocably submits to the exclusive
jurisdiction of the state and federal courts sitting in the City of New York,
borough of Manhattan for the adjudication of any dispute hereunder or in
connection herewith or with any transaction contemplated hereby or discussed
herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the
jurisdiction of any such court, that such suit, action or proceeding is improper
or inconvenient venue for such proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the
address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. The parties hereby waive all
rights to a trial by jury. If either party shall commence an action or
proceeding to enforce any provisions of the Transaction Documents, then the
prevailing party in such action or proceeding shall be reimbursed by the other
party for its attorneys' fees and other costs and expenses incurred with the
investigation, preparation and prosecution of such action or proceeding.

     5.10 Survival. The representations and warranties contained herein shall
survive the Closing and the delivery, exercise and/or conversion of the
Securities, as applicable for the applicable statue of limitations.

     5.11 Execution. This Agreement may be executed in two or more counterparts,
all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and
delivered to the other party, it being understood that both parties need not
sign the same counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile signature page
were an original thereof.

                                       30
<PAGE>

     5.12 Severability. If any provision of this Agreement is held to be invalid
or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be
affected or impaired thereby and the parties will attempt to agree upon a valid
and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

     5.13 Rescission and Withdrawal Right. Notwithstanding anything to the
contrary contained in (and without limiting any similar provisions of) the
Transaction Documents, whenever any Purchaser exercises a right, election,
demand or option under a Transaction Document and the Company does not timely
perform its related obligations within the periods therein provided, then such
Purchaser may rescind or withdraw, in its sole discretion from time to time upon
written notice to the Company, any relevant notice, demand or election in whole
or in part without prejudice to its future actions and rights; provided,
however, in the case of a rescission of a conversion of a Debenture or exercise
of a Warrant, the Purchaser shall be required to return any shares of Common
Stock subject to any such rescinded conversion or exercise notice.

     5.14 Replacement of Securities. If any certificate or instrument evidencing
any Securities is mutilated, lost, stolen or destroyed, the Borrowers shall
issue or cause to be issued in exchange and substitution for and upon
cancellation thereof, or in lieu of and substitution therefor, a new certificate
or instrument, but only upon receipt of evidence reasonably satisfactory to the
Borrowers of such loss, theft or destruction and customary and reasonable
indemnity, if requested. The applicants for a new certificate or instrument
under such circumstances shall also pay any reasonable third-party costs
associated with the issuance of such replacement Securities.

     5.15 Remedies. In addition to being entitled to exercise all rights
provided herein or granted by law, including recovery of damages, each of the
Purchasers and the Borrowers will be entitled to specific performance under the
Transaction Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of
obligations described in the foregoing sentence and hereby agrees to waive in
any action for specific performance of any such obligation the defense that a
remedy at law would be adequate.

     5.16 Payment Set Aside. To the extent that the Borrowers make a payment or
payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently
invalidated, declared to be fraudulent or preferential, set aside, recovered
from, disgorged by or are required to be refunded, repaid or otherwise restored
to the Borrowers, a trustee, receiver or any other person under any law
(including, without limitation, any bankruptcy law, state or federal law, common
law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be
revived and continued in full force and effect as if such payment had not been
made or such enforcement or setoff had not occurred.

                                       31
<PAGE>

     5.17 Usury. To the extent it may lawfully do so, the Borrowers hereby agree
not to insist upon or plead or in any manner whatsoever claim, and will resist
any and all efforts to be compelled to take the benefit or advantage of, usury
laws wherever enacted, now or at any time hereafter in force, in connection with
any claim, action or proceeding that may be brought by any Purchaser in order to
enforce any right or remedy under any Transaction Document. Notwithstanding any
provision to the contrary contained in any Transaction Document, it is expressly
agreed and provided that the total liability of the Borrowers under the
Transaction Documents for payments in the nature of interest shall not exceed
the maximum lawful rate authorized under applicable law (the "Maximum Rate"),
and, without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums in the
nature of interest that the Borrowers may be obligated to pay under the
Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum
contract rate of interest allowed by law and applicable to the Transaction
Documents is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest
allowed by law will be the Maximum Rate applicable to the Transaction Documents
from the effective date forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the
Maximum Rate is paid by the Borrowers to any Purchaser with respect to
indebtedness evidenced by the Transaction Documents, such excess shall be
applied by such Purchaser to the unpaid principal balance of any such
indebtedness or be refunded to the Borrowers, the manner of handling such excess
to be at such Purchaser's election.

     5.18 Independent Nature of Purchasers' Obligations and Rights. The
obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be
responsible in any way for the performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or in any
Transaction Document, and no action taken by any Purchaser pursuant thereto,
shall be deemed to constitute the Purchasers as a partnership, an association, a
joint venture or any other kind of entity, or create a presumption that the
Purchasers are in any way acting in concert or as a group with respect to such
obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights,
including without limitation the rights arising out of this Agreement or out of
the other Transaction Documents, and it shall not be necessary for any other
Purchaser to be joined as an additional party in any proceeding for such
purpose. Each Purchaser has been represented by its own separate legal counsel
in their review and negotiation of the Transaction Documents. For reasons of
administrative convenience only, Purchasers and their respective counsel have
chosen to communicate with the Borrowers through FW. FW does not represent all
of the Purchasers but only DKR SoundShore Oasis Holding Fund Ltd. The Borrowers
have elected to provide all Purchasers with the same terms and Transaction
Documents for the convenience of the Borrowers and not because it was required
or requested to do so by the Purchasers.

     5.19 Liquidated Damages. The Borrowers' obligations to pay any partial
liquidated damages or other amounts owing under the Transaction Documents is a
continuing obligation of the Company and shall not terminate until all unpaid
partial liquidated damages and other amounts have been paid notwithstanding the
fact that the instrument or security pursuant to

                                       32
<PAGE>

which such partial liquidated damages or other amounts are due and payable shall
have been canceled.

     5.20 Construction. The parties agree that each of them and/or their
respective counsel has reviewed and had an opportunity to revise the Transaction
Documents and, therefore, the normal rule of construction to the effect that any
ambiguities are to be resolved against the drafting party shall not be employed
in the interpretation of the Transaction Documents or any amendments hereto.

                            (Signature Pages Follow)

                                       33
<PAGE>

     IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

VELOCITY ASSET MANAGEMENT INC.                     Address for Notice:
                                                   -------------------

By: /s/ JAMES J. MASTRIANI
    ----------------------
    Name: James J. Mastriani
    Title: CFO and Chief Legal Counsel

With a copy to (which shall not constitute notice):

J. HOLDER INC.                                     Address for Notice:
                                                   -------------------

By: /s/ W. PETER RAGAN, SR.
    -----------------------
    Name: W. Peter Ragan, Sr.
    Title: President

With a copy to (which shall not constitute notice):

                   [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK
                      SIGNATURE PAGE FOR PURCHASER FOLLOWS]

                                       34
<PAGE>

        [PURCHASER SIGNATURE PAGES TO VCYA SECURITIES PURCHASE AGREEMENT]

     IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

Name of Purchaser: DKR SoundShore Oasis Holding Fund, Ltd.
Signature of Authorized Signatory of Purchaser: /s/ BRAD CASWELL
Name of Authorized Signatory: Brad Caswell
Title of Authorized Signatory: Director
Email Address of Purchaser:

Address for Notice of Purchaser:

Address for Delivery of Securities for Purchaser (if not same as above):

Subscription Amount: $1,800,000
Warrant Shares:
EIN Number:

                           [SIGNATURE PAGES CONTINUE]

                                       35
<PAGE>

                                                                         Annex A

                                CLOSING STATEMENT

Pursuant to the attached Securities Purchase Agreement, dated as of the date
hereto, the purchasers shall purchase up to $3,000,000 of Debentures and
Warrants from Velocity Asset Management Inc. (the "Company") and J. Holder Inc.
(the "Subsidiary", and the Company and Subsidiary, collectively, the
"Borrowers"). All funds will be wired into a trust account maintained by
____________, counsel to the Borrowers. All funds will be disbursed in
accordance with this Closing Statement.

Disbursement Date: October __, 2005

--------------------------------------------------------------------------------

I.   PURCHASE PRICE
     --------------

                    Gross Proceeds to be Received in Trust      $

II.  DISBURSEMENTS
     -------------
                                                                $
                                                                $
                                                                $
                                                                $
                                                                $

Total Amount Disbursed:                                         $

WIRE INSTRUCTIONS:
-----------------

To: _____________________________________

To: _____________________________________

                                       36

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00092-of-00352.parquet"}]]